DRUG,GENE,TISSUE,Barrier ratio,KO ratio,Method,dose (mg/kg),Admin Route,time,JOURNAL,YEAR,VOL,PAGE,NOTES: 
Abermaciclib,abcb1a/1b -/-,Brain,0.661261261,12.81229504,LC-MS,10,PO,4,Pharmacological Research,2022,178,105954,
Abermaciclib,abcg2 -/-,Brain,0.126490066,2.450813534,LC-MS,10,PO,4,Pharmacological Research,2022,178,105954,
Abermaciclib,TKO,Brain,4.869466515,94.3485508,LC-MS,10,PO,4,Pharmacological Research,2022,178,105954,
Abermaciclib,WT,Brain,0.051611461,,LC-MS,5,IV,4,Pharmacological Research,2022,178,105954,
Abermaciclib,TKO,Brain,3.073684211,44.0172647,LC-MS,10,PO,24,Pharmacological Research,2022,178,105954,
Abermaciclib,WT,Brain,0.06982906,,LC-MS,10,PO,24,Pharmacological Research,2022,178,105954,
Afatinib,abcb1a/1b -/-,Brain,0.677083333,1.5931373,LC-MS,10,PO,2,Pharmacological Research,2017,120,43-50,
Afatinib,abcg2 -/-,Brain,0.361111111,0.8496732,LC-MS,10,PO,2,Pharmacological Research,2017,120,43-50,
Afatinib,TKO,Brain,11.72435897,27.586727,LC-MS,10,PO,2,Pharmacological Research,2017,120,43-50,
Afatinib,WT,Brain,0.425,,LC-MS,10,PO,2,Pharmacological Research,2017,120,43-50,
Afatinib,abcb1a/1b -/-,Brain,0.041984733,1.8078132,LC-MS,10,PO,24,Pharmacological Research,2017,120,43-50,
Afatinib,abcg2 -/-,Brain,0.046706587,2.0111307,LC-MS,10,PO,24,Pharmacological Research,2017,120,43-50,
Afatinib,TKO,Brain,9.04845815,389.6159627,LC-MS,10,PO,24,Pharmacological Research,2017,120,43-50,
Afatinib,WT,Brain,0.023224044,,LC-MS,10,PO,24,Pharmacological Research,2017,120,43-50,
Afatinib,abcg2 -/-,Liver,0.108888889,1.3066667,LC-MS,10,PO,2,Pharmacological Research,2017,120,43-50,
Afatinib,TKO,Liver,0.091987179,1.103846154,LC-MS,10,PO,2,Pharmacological Research,2017,120,43-50,
Afatinib,abcg2 -/-,Liver,2.221556886,12.906188,LC-MS,10,PO,24,Pharmacological Research,2017,120,43-50,
Afatinib,TKO,Liver,15.85022026,92.08223201,LC-MS,10,PO,24,Pharmacological Research,2017,120,43-50,
Afatinib,abcb1a/1b -/-,Liver,0.078125,0.9375,LC-MS,10,PO,2,Pharmacological Research,2017,120,43-50,
Afatinib,WT,Liver,0.083333333,,LC-MS,10,PO,2,Pharmacological Research,2017,120,43-50,
Afatinib,abcb1a/1b -/-,Liver,0.171755725,0.997819,LC-MS,10,PO,24,Pharmacological Research,2017,120,43-50,
Afatinib,WT,Liver,0.172131148,,LC-MS,10,PO,24,Pharmacological Research,2017,120,43-50,
Aripiprazole,abcb1a/1b -/-,Brain,3.23,2.118828769,HPLC,2,IP,1,Schizophrenial Research,2009,110,90-94,
Aripiprazole,WT,Brain,1.525,,HPLC,2,IP,1,Schizophrenial Research,2009,110,90-94,
Aripiprazole,abcb1a/1b -/-,Brain,3.045454545,3.506887052,HPLC,2,IP,2,Schizophrenial Research,2009,110,90-94,
Aripiprazole,WT,Brain,0.868421053,,HPLC,2,IP,2,Schizophrenial Research,2009,110,90-94,
Aripiprazole,abcb1a/1b -/-,Brain,2.865168539,2.731904886,HPLC,2,IP,3,Schizophrenial Research,2009,110,90-94,
Aripiprazole,WT,Brain,1.048780488,,HPLC,2,IP,3,Schizophrenial Research,2009,110,90-94,
Aripiprazole,abcb1a/1b -/-,Muscle,1.780346821,4.02226504,HPLC,2,IP,1,Schizophrenial Research,2009,110,90-94,
Aripiprazole,WT,Muscle,0.442622951,,HPLC,2,IP,1,Schizophrenial Research,2009,110,90-94,
Aripiprazole,abcb1a/1b -/-,Muscle,1.166666667,1.6625,HPLC,2,IP,2,Schizophrenial Research,2009,110,90-94,
Aripiprazole,WT,Muscle,0.701754386,,HPLC,2,IP,2,Schizophrenial Research,2009,110,90-94,
Aripiprazole,abcb1a/1b -/-,Muscle,1.348314607,2.167878387,HPLC,2,IP,3,Schizophrenial Research,2009,110,90-94,
Aripiprazole,WT,Muscle,0.62195122,,HPLC,2,IP,3,Schizophrenial Research,2009,110,90-94,
Aripiprazole,abcb1a/1b -/-,Teste,5.601156069,2.005893465,HPLC,2,IP,1,Schizophrenial Research,2009,110,90-94,
Aripiprazole,WT,Teste,2.792349727,,HPLC,2,IP,1,Schizophrenial Research,2009,110,90-94,
Aripiprazole,abcb1a/1b -/-,Teste,5.060606061,1.214545455,HPLC,2,IP,2,Schizophrenial Research,2009,110,90-94,
Aripiprazole,WT,Teste,4.166666667,,HPLC,2,IP,2,Schizophrenial Research,2009,110,90-94,
Aripiprazole,abcb1a/1b -/-,Teste,8.651685393,2.09273806,HPLC,2,IP,3,Schizophrenial Research,2009,110,90-94,
Aripiprazole,WT,Teste,4.134146341,,HPLC,2,IP,3,Schizophrenial Research,2009,110,90-94,
Axtinib,abcb1a/1b -/-,Brain,0.67368421,7.34315783,LC-MS,10,PO,1,Drug Metab Dispos,2011,39,729-735,
Axtinib,abcg2 -/-,Brain,0.045454545,0.495454537,LC-MS,10,PO,1,Drug Metab Dispos,2011,39,729-735,
Axtinib,TKO,Brain,1.4,15.25999988,LC-MS,10,PO,1,Drug Metab Dispos,2011,39,729-735,
Axtinib,WT,Brain,0.09174312,,LC-MS,10,PO,1,Drug Metab Dispos,2011,39,729-735,
Axtinib,abcb1a/1b -/-,Brain,0.04759494,5.314770603,LC-MS,10,PO,4,Drug Metab Dispos,2011,39,729-735,
Axtinib,abcg2 -/-,Brain,0.005993151,0.669235485,LC-MS,10,PO,4,Drug Metab Dispos,2011,39,729-735,
Axtinib,TKO,Brain,0.20193861,22.54982122,LC-MS,10,PO,4,Drug Metab Dispos,2011,39,729-735,
Axtinib,WT,Brain,0.00895522,,LC-MS,10,PO,4,Drug Metab Dispos,2011,39,729-735,
AZD1775,abcb1a/1b -/-,Brain,3.93,3.508928571,LC-MS,20,IV,1,Investigational New Drugs,2018,36,380-387,
AZD1775,abcg2 -/-,Brain,0.56,0.5,LC-MS,20,IV,1,Investigational New Drugs,2018,36,380-387,
AZD1775,TKO,Brain,25.54,22.80357143,LC-MS,20,IV,1,Investigational New Drugs,2018,36,380-387,
AZD1775,WT,Brain,1.12,,LC-MS,20,IV,1,Investigational New Drugs,2018,36,380-387,
AZD2461,abcb1a/1b -/-,Brain,0.68,8.5,LC-MS,10,IV,1,Mol Pharmaceuticals,2018,15,5236-5243,
AZD2461,abcb1a/1b -/-,Brain,0.53,10.6,LC-MS,100,PO,1,Mol Pharmaceuticals,2018,15,5236-5243,
AZD2461,abcg2 -/-,Brain,0.1,1.25,LC-MS,10,IV,1,Mol Pharmaceuticals,2018,15,5236-5243,
AZD2461,abcg2 -/-,Brain,0.05,1,LC-MS,100,PO,1,Mol Pharmaceuticals,2018,15,5236-5243,
AZD2461,TKO,Brain,0.71,8.875,LC-MS,10,IV,1,Mol Pharmaceuticals,2018,15,5236-5243,
AZD2461,TKO,Brain,0.54,10.8,LC-MS,100,PO,1,Mol Pharmaceuticals,2018,15,5236-5243,
AZD2461,WT,Brain,0.08,,LC-MS,10,IV,1,Mol Pharmaceuticals,2018,15,5236-5243,
AZD2461,WT,Brain,0.05,,LC-MS,100,PO,1,Mol Pharmaceuticals,2018,15,5236-5243,
AZD2461,abcb1a/1b -/-,Brain,0.46,7.666667,LC-MS,100,PO,4,Mol Pharmaceuticals,2018,15,5236-5243,
AZD2461,abcg2 -/-,Brain,0.03,0.5,LC-MS,100,PO,4,Mol Pharmaceuticals,2018,15,5236-5243,
AZD2461,TKO,Brain,0.42,7,LC-MS,100,PO,4,Mol Pharmaceuticals,2018,15,5236-5243,
AZD2461,WT,Brain,0.06,,LC-MS,100,PO,4,Mol Pharmaceuticals,2018,15,5236-5243,
AZD2461,abcb1a/1b -/-,Brain,0.49,8.16666667,LC-MS,100,PO,7,Mol Pharmaceuticals,2018,15,5236-5243,
AZD2461,abcg2 -/-,Brain,0.33,5.5,LC-MS,100,PO,7,Mol Pharmaceuticals,2018,15,5236-5243,
AZD2461,TKO,Brain,0.56,9.33333333,LC-MS,100,PO,7,Mol Pharmaceuticals,2018,15,5236-5243,
AZD2461,WT,Brain,0.06,,LC-MS,100,PO,7,Mol Pharmaceuticals,2018,15,5236-5243,
Brigatinib,abcb1a/1b -/-,Brain,1.86,20.66666667,LC-MS,10,PO,8,Pharmacological Research,2018,137,47-55,
Brigatinib,abcg2 -/-,Brain,0.13,1.444444444,LC-MS,10,PO,8,Pharmacological Research,2018,137,47-55,
Brigatinib,cyp1aXAV,Brain,0.12,1.333333333,LC-MS,10,PO,8,Pharmacological Research,2018,137,47-55,
Brigatinib,cyp3a-/-,Brain,0.11,1.222222222,LC-MS,10,PO,8,Pharmacological Research,2018,137,47-55,
Brigatinib,TKO,Brain,4.31,47.88888889,LC-MS,10,PO,8,Pharmacological Research,2018,137,47-55,
Brigatinib,WT,Brain,0.09,,LC-MS,10,PO,8,Pharmacological Research,2018,137,47-55,
Brigatinib,abcb1a/1b -/-,Teste,2.11,2.397727273,LC-MS,10,PO,8,Pharmacological Research,2018,137,47-55,
Brigatinib,abcg2 -/-,Teste,1.28,1.454545455,LC-MS,10,PO,8,Pharmacological Research,2018,137,47-55,
Brigatinib,cyp1aXAV,Teste,1.37,1.556818182,LC-MS,10,PO,8,Pharmacological Research,2018,137,47-55,
Brigatinib,cyp3a-/-,Teste,0.89,1.011363636,LC-MS,10,PO,8,Pharmacological Research,2018,137,47-55,
Brigatinib,TKO,Teste,3.11,3.534090909,LC-MS,10,PO,8,Pharmacological Research,2018,137,47-55,
Brigatinib,WT,Teste,0.88,,LC-MS,10,PO,8,Pharmacological Research,2018,137,47-55,
Buparlisib,abcb1a/1b -/-,Brain,2.083043959,1.116186131,LC-MS,2,IV,1,Scientific Reports,2018,8,10784,
Buparlisib,abcg2 -/-,Brain,1.443727438,0.773612355,LC-MS,2,IV,1,Scientific Reports,2018,8,10784,
Buparlisib,TKO,Brain,1.926959468,1.032549229,LC-MS,2,IV,1,Scientific Reports,2018,8,10784,
Buparlisib,WT,Brain,1.86621559,,LC-MS,2,IV,1,Scientific Reports,2018,8,10784,
Buparlisib,abcg2 -/-,Kidney,0.507574387,0.754713768,LC-MS,2,IV,1,Scientific Reports,2018,8,10784,
Buparlisib,TKO,Kidney,0.517912693,0.770085823,LC-MS,2,IV,1,Scientific Reports,2018,8,10784,
Buparlisib,abcb1a/1b -/-,Kidney,0.531069685,0.789648991,LC-MS,2,IV,1,Scientific Reports,2018,8,10784,
Buparlisib,WT,Kidney,0.672538926,,LC-MS,2,IV,1,Scientific Reports,2018,8,10784,
Buparlisib,abcg2 -/-,Liver,0.840623169,0.800873329,LC-MS,2,IV,1,Scientific Reports,2018,8,10784,
Buparlisib,TKO,Liver,0.927888514,0.884012232,LC-MS,2,IV,1,Scientific Reports,2018,8,10784,
Buparlisib,abcb1a/1b -/-,Liver,0.992480614,0.945550019,LC-MS,2,IV,1,Scientific Reports,2018,8,10784,
Buparlisib,WT,Liver,1.049633117,,LC-MS,2,IV,1,Scientific Reports,2018,8,10784,
Buparlisib,abcg2 -/-,Spleen,0.239718149,0.710889675,LC-MS,2,IV,1,Scientific Reports,2018,8,10784,
Buparlisib,TKO,Spleen,0.224021932,0.664342182,LC-MS,2,IV,1,Scientific Reports,2018,8,10784,
Buparlisib,abcb1a/1b -/-,Spleen,0.25743018,0.763415111,LC-MS,2,IV,1,Scientific Reports,2018,8,10784,
Buparlisib,WT,Spleen,0.337208652,,LC-MS,2,IV,1,Scientific Reports,2018,8,10784,
Cabazitaxel,abcb1a/1b -/-,Brain,0.158368298,1.524102301,LC-MS,10,PO,1,Mol Pharm,2015,10,3714-3723,
Cabazitaxel,abcg2 -/-,Brain,0.012005653,0.115539816,LC-MS,10,PO,1,Mol Pharm,2015,10,3714-3723,
Cabazitaxel,TKO,Brain,0.219720339,2.114541096,LC-MS,10,PO,1,Mol Pharm,2015,10,3714-3723,
Cabazitaxel,WT,Brain,0.103909231,,LC-MS,10,PO,1,Mol Pharm,2015,10,3714-3723,
Cabazitaxel,abcg2 -/-,Liver,2.898622639,0.164288946,LC-MS,10,PO,1,Mol Pharm,2015,10,3714-3723,
Cabazitaxel,TKO,Liver,2.534539842,0.14365336,LC-MS,10,PO,1,Mol Pharm,2015,10,3714-3723,
Cabazitaxel,abcb1a/1b -/-,Liver,2.304117544,0.13059342,LC-MS,10,PO,1,Mol Pharm,2015,10,3714-3723,
Cabazitaxel,WT,Liver,17.64344286,,LC-MS,10,PO,1,Mol Pharm,2015,10,3714-3723,
Cediranib,abcb1a/1b -/-,Brain,2.1009434,23.66416791,LC-MS,4,IV,24,J Pharmacol Exp Ther,2012,341,386-395,
Cediranib,abcg2 -/-,Brain,0.076857143,0.865687451,LC-MS,4,IV,24,J Pharmacol Exp Ther,2012,341,386-395,
Cediranib,TKO,Brain,1.66666667,22.95197891,LC-MS,5,PO,24,J Pharmacol Exp Ther,2012,341,386-395,
Cediranib,TKO,Brain,2.03474771,22.91856671,LC-MS,4,IV,24,J Pharmacol Exp Ther,2012,341,386-395,
Cediranib,WT,Brain,0.08878163,,LC-MS,4,IV,24,J Pharmacol Exp Ther,2012,341,386-395,
Cediranib,WT,Brain,0.07261538,,LC-MS,5,PO,24,J Pharmacol Exp Ther,2012,341,386-395,
Ceritinib,abcb1a/1b -/-,Brain,1.157894737,50.1754386,LC-MS,20,PO,3,Pharmacological Research,2015,102,200-207,
Ceritinib,abcg2 -/-,Brain,0.013636364,0.590909091,LC-MS,20,PO,3,Pharmacological Research,2015,102,200-207,
Ceritinib,TKO,Brain,2.363636364,102.4242424,LC-MS,20,PO,3,Pharmacological Research,2015,102,200-207,
Ceritinib,WT,Brain,0.023076923,,LC-MS,20,PO,3,Pharmacological Research,2015,102,200-207,
Ceritinib,abcb1a/1b -/-,Brain,4.761904762,77.38095238,LC-MS,20,PO,24,Pharmacological Research,2015,102,200-207,
Ceritinib,abcg2 -/-,Brain,0.061904762,1.005952381,LC-MS,20,PO,24,Pharmacological Research,2015,102,200-207,
Ceritinib,TKO,Brain,14.09090909,228.9772727,LC-MS,20,PO,24,Pharmacological Research,2015,102,200-207,
Ceritinib,WT,Brain,0.061538462,,LC-MS,20,PO,24,Pharmacological Research,2015,102,200-207,
Ciprofloxacin,abcc2 -/-,Brain,0.2,1,Radio-Labeled,8-12,IV,1.5,European Journal of Pharmacuetical Sciences,2021,163,105854,abcc4 -/- from C57BL/6 mice not FVB; lung and brain data based on AUC
Ciprofloxacin,abcc2 -/-; abcc4-/-,Brain,0.18,0.9,Radio-Labeled,8-12,IV,1.5,European Journal of Pharmacuetical Sciences,2021,163,105854,abcc4 -/- from C57BL/6 mice not FVB; lung and brain data based on AUC
Ciprofloxacin,abcc4 -/-,Brain,0.21,1.05,Radio-Labeled,8-12,IV,1.5,European Journal of Pharmacuetical Sciences,2021,163,105854,abcc4 -/- from C57BL/6 mice not FVB; lung and brain data based on AUC
Ciprofloxacin,TKO,Brain,0.22,1.1,Radio-Labeled,8-12,IV,1.5,European Journal of Pharmacuetical Sciences,2021,163,105854,abcc4 -/- from C57BL/6 mice not FVB; lung and brain data based on AUC
Ciprofloxacin,WT,Brain,0.2,,Radio-Labeled,8-12,IV,1.5,European Journal of Pharmacuetical Sciences,2021,163,105854,abcc4 -/- from C57BL/6 mice not FVB; lung and brain data based on AUC
Ciprofloxacin,abcc2 -/-,Kidney,1.186666667,,Radio-Labeled,8-12,IV,1.5,European Journal of Pharmacuetical Sciences,2021,163,105854,abcc4 -/- from C57BL/6 mice not FVB; lung and brain data based on AUC
Ciprofloxacin,abcc4 -/-,Kidney,1.037974684,,Radio-Labeled,8-12,IV,1.5,European Journal of Pharmacuetical Sciences,2021,163,105854,abcc4 -/- from C57BL/6 mice not FVB; lung and brain data based on AUC
Ciprofloxacin,abcc2 -/-,Liver,1.253333333,1.514444444,Radio-Labeled,8-12,IV,1.5,European Journal of Pharmacuetical Sciences,2021,163,105854,abcc4 -/- from C57BL/6 mice not FVB; lung and brain data based on AUC
Ciprofloxacin,abcc4 -/-,Liver,1.063291139,1.284810127,Radio-Labeled,8-12,IV,1.5,European Journal of Pharmacuetical Sciences,2021,163,105854,abcc4 -/- from C57BL/6 mice not FVB; lung and brain data based on AUC
Ciprofloxacin,TKO,Liver,1.042253521,1.259389671,Radio-Labeled,8-12,IV,1.5,European Journal of Pharmacuetical Sciences,2021,163,105854,abcc4 -/- from C57BL/6 mice not FVB; lung and brain data based on AUC
Ciprofloxacin,WT,Liver,0.827586207,,Radio-Labeled,8-12,IV,1.5,European Journal of Pharmacuetical Sciences,2021,163,105854,abcc4 -/- from C57BL/6 mice not FVB; lung and brain data based on AUC
Ciprofloxacin,abcc2 -/-,Lung,0.63,0.9,Radio-Labeled,8-12,IV,1.5,European Journal of Pharmacuetical Sciences,2021,163,105854,abcc4 -/- from C57BL/6 mice not FVB; lung and brain data based on AUC
Ciprofloxacin,abcc2 -/-; abcc4-/-,Lung,0.63,0.9,Radio-Labeled,8-12,IV,1.5,European Journal of Pharmacuetical Sciences,2021,163,105854,abcc4 -/- from C57BL/6 mice not FVB; lung and brain data based on AUC
Ciprofloxacin,abcc4 -/-,Lung,0.65,0.928571429,Radio-Labeled,8-12,IV,1.5,European Journal of Pharmacuetical Sciences,2021,163,105854,abcc4 -/- from C57BL/6 mice not FVB; lung and brain data based on AUC
Ciprofloxacin,TKO,Lung,0.56,0.8,Radio-Labeled,8-12,IV,1.5,European Journal of Pharmacuetical Sciences,2021,163,105854,abcc4 -/- from C57BL/6 mice not FVB; lung and brain data based on AUC
Ciprofloxacin,WT,Lung,0.7,,Radio-Labeled,8-12,IV,1.5,European Journal of Pharmacuetical Sciences,2021,163,105854,abcc4 -/- from C57BL/6 mice not FVB; lung and brain data based on AUC
Citalopram,abcb1a/1b -/-,Brain,19.23529412,0.293603551,HPLC,1,SC,1,Journal of Psychiatric Research,2003,37,179-193,
Citalopram,WT,Brain,15.74740484,,HPLC,1,SC,1,Journal of Psychiatric Research,2003,37,179-193,
Citalopram,abcb1a/1b -/-,Kidney,4.432525952,1.021001061,HPLC,1,SC,1,Journal of Psychiatric Research,2003,37,179-193,
Citalopram,WT,Kidney,15.07831325,,HPLC,1,SC,1,Journal of Psychiatric Research,2003,37,179-193,
Citalopram,abcb1a/1b -/-,Liver,0.25669197,0.87320006,HPLC,1,SC,1,Journal of Psychiatric Research,2003,37,179-193,
Citalopram,WT,Liver,3.870481928,,HPLC,1,SC,1,Journal of Psychiatric Research,2003,37,179-193,
Citalopram,abcb1a/1b -/-,Spleen,14.76816609,0.956606241,HPLC,1,SC,1,Journal of Psychiatric Research,2003,37,179-193,
Citalopram,WT,Spleen,18.40060241,,HPLC,1,SC,1,Journal of Psychiatric Research,2003,37,179-193,
Cobimetinib,abcb1a/1b -/-,Brain,0.0932,1.21038961,LC-MS,10,PO,1,Mol Pharm,2014,11,4199-4207,
Cobimetinib,abcg2 -/-,Brain,0.0058,0.075324675,LC-MS,10,PO,1,Mol Pharm,2014,11,4199-4207,
Cobimetinib,TKO,Brain,0.089,1.155844156,LC-MS,10,PO,1,Mol Pharm,2014,11,4199-4207,
Cobimetinib,WT,Brain,0.077,,LC-MS,10,PO,1,Mol Pharm,2014,11,4199-4207,
Cobimetinib,abcb1a/1b -/-,Brain,0.9154,35.20769231,LC-MS,10,PO,6,Mol Pharm,2014,11,4199-4207,
Cobimetinib,abcg2 -/-,Brain,0.0182,0.7,LC-MS,10,PO,6,Mol Pharm,2014,11,4199-4207,
Cobimetinib,TKO,Brain,0.5289,20.34230769,LC-MS,10,PO,6,Mol Pharm,2014,11,4199-4207,
Cobimetinib,WT,Brain,0.026,,LC-MS,10,PO,6,Mol Pharm,2014,11,4199-4207,
Crizotinib,abcb1a/1b -/-,Brain,2.81905821,12.55294911,LC-MS,5,PO,4,Int J Cancer,2014,134,1484-1494,
Crizotinib,abcg2 -/-,Brain,0.139769452,0.622377648,LC-MS,5,PO,4,Int J Cancer,2014,134,1484-1494,
Crizotinib,TKO,Brain,3.41239892,15.19502855,LC-MS,5,PO,4,Int J Cancer,2014,134,1484-1494,
Crizotinib,WT,Brain,0.22457338,,LC-MS,5,PO,4,Int J Cancer,2014,134,1484-1494,
Crizotinib,abcb1a/1b -/-,Brain,2.53155738,66.11258654,LC-MS,5,PO,24,Int J Cancer,2014,134,1484-1494,
Crizotinib,abcg2 -/-,Brain,0.036315323,0.948388511,LC-MS,5,PO,24,Int J Cancer,2014,134,1484-1494,
Crizotinib,TKO,Brain,3.22942135,84.33757029,LC-MS,5,PO,24,Int J Cancer,2014,134,1484-1494,
Crizotinib,WT,Brain,0.03829161,,LC-MS,5,PO,24,Int J Cancer,2014,134,1484-1494,
Cyclosporin A,abcb1a -/-,Brain,3.296296296,11.92945326,Radio-Labeled,1,IV,4,J Clin Invest,1995,96,1698-1711,
Cyclosporin A,WT,Brain,0.276315789,,Radio-Labeled,1,IV,4,J Clin Invest,1995,96,1698-1711,
Cyclosporin A,abcb1a -/-,Gall Bladder,67.05555556,0.388905847,Radio-Labeled,1,IV,4,J Clin Invest,1995,96,1698-1711,
Cyclosporin A,WT,Gall Bladder,172.4210526,,Radio-Labeled,1,IV,4,J Clin Invest,1995,96,1698-1711,
Cyclosporin A,abcb1a -/-,Heart,8.907407407,1.120799608,Radio-Labeled,1,IV,4,J Clin Invest,1995,96,1698-1711,
Cyclosporin A,WT,Heart,7.947368421,,Radio-Labeled,1,IV,4,J Clin Invest,1995,96,1698-1711,
Cyclosporin A,abcb1a -/-,Kidney,26.98148148,0.731309769,Radio-Labeled,1,IV,4,J Clin Invest,1995,96,1698-1711,
Cyclosporin A,WT,Kidney,36.89473684,,Radio-Labeled,1,IV,4,J Clin Invest,1995,96,1698-1711,
Cyclosporin A,abcb1a -/-,Liver,118.462963,0.846164021,Radio-Labeled,1,IV,4,J Clin Invest,1995,96,1698-1711,
Cyclosporin A,WT,Liver,140,,Radio-Labeled,1,IV,4,J Clin Invest,1995,96,1698-1711,
Cyclosporin A,abcb1a -/-,Lung,13.09259259,0.823706156,Radio-Labeled,1,IV,4,J Clin Invest,1995,96,1698-1711,
Cyclosporin A,WT,Lung,15.89473684,,Radio-Labeled,1,IV,4,J Clin Invest,1995,96,1698-1711,
Cyclosporin A,abcb1a -/-,Lymph Node,15.2962963,0.951324483,Radio-Labeled,1,IV,4,J Clin Invest,1995,96,1698-1711,
Cyclosporin A,WT,Lymph Node,16.07894737,,Radio-Labeled,1,IV,4,J Clin Invest,1995,96,1698-1711,
Cyclosporin A,abcb1a -/-,Muscle,3.12962963,1.251851852,Radio-Labeled,1,IV,4,J Clin Invest,1995,96,1698-1711,
Cyclosporin A,WT,Muscle,2.5,,Radio-Labeled,1,IV,4,J Clin Invest,1995,96,1698-1711,
Cyclosporin A,abcb1a -/-,Small Gut,38,1.34953271,Radio-Labeled,1,IV,4,J Clin Invest,1995,96,1698-1711,
Cyclosporin A,WT,Small Gut,28.15789474,,Radio-Labeled,1,IV,4,J Clin Invest,1995,96,1698-1711,
Cyclosporin A,abcb1a -/-,Spleen,19.90740741,1.068476669,Radio-Labeled,1,IV,4,J Clin Invest,1995,96,1698-1711,
Cyclosporin A,WT,Spleen,18.63157895,,Radio-Labeled,1,IV,4,J Clin Invest,1995,96,1698-1711,
Cyclosporin A,abcb1a -/-,Stomach,22.2037037,0.990306034,Radio-Labeled,1,IV,4,J Clin Invest,1995,96,1698-1711,
Cyclosporin A,WT,Stomach,22.42105263,,Radio-Labeled,1,IV,4,J Clin Invest,1995,96,1698-1711,
Cyclosporin A,abcb1a -/-,Teste,2.740740741,1.827160494,Radio-Labeled,1,IV,4,J Clin Invest,1995,96,1698-1711,
Cyclosporin A,WT,Teste,1.5,,Radio-Labeled,1,IV,4,J Clin Invest,1995,96,1698-1711,
Cyclosporin A,abcb1a -/-,Thymus,10.12962963,0.796948087,Radio-Labeled,1,IV,4,J Clin Invest,1995,96,1698-1711,
Cyclosporin A,WT,Thymus,12.71052632,,Radio-Labeled,1,IV,4,J Clin Invest,1995,96,1698-1711,
D9-THC,abcb1a/1b -/-,Brain,1.8,1.5,GC-MS,3,IP,0.5,PLOS ONE,2012,7,e35937,
D9-THC,abcg2 -/-,Brain,3.33,2.775,GC-MS,3,IP,0.5,PLOS ONE,2012,7,e35937,
D9-THC,WT,Brain,1.2,,GC-MS,3,IP,0.5,PLOS ONE,2012,7,e35937,
D9-THC,abcb1a/1b -/-,Brain,3.2,1.516587678,GC-MS,3,IP,1,PLOS ONE,2012,7,e35937,
D9-THC,abcg2 -/-,Brain,1.93,0.914691943,GC-MS,3,IP,1,PLOS ONE,2012,7,e35937,
D9-THC,WT,Brain,2.11,,GC-MS,3,IP,1,PLOS ONE,2012,7,e35937,
D9-THC,abcb1a/1b -/-,Brain,4.18,3.215384615,GC-MS,3,IP,2,PLOS ONE,2012,7,e35937,
D9-THC,abcg2 -/-,Brain,6.09,4.684615385,GC-MS,3,IP,2,PLOS ONE,2012,7,e35937,
D9-THC,WT,Brain,1.3,,GC-MS,3,IP,2,PLOS ONE,2012,7,e35937,
D9-THC,abcb1a/1b -/-,Brain,1.54,0.922155689,GC-MS,3,IP,3,PLOS ONE,2012,7,e35937,
D9-THC,abcg2 -/-,Brain,2.4,1.437125749,GC-MS,3,IP,3,PLOS ONE,2012,7,e35937,
D9-THC,WT,Brain,1.67,,GC-MS,3,IP,3,PLOS ONE,2012,7,e35937,
Dasatinib,TKO,Brain,0.079432823,3.89045145,HPLC,15,PO,0.5,Mol Cancer Ther,2012,11,2183-2191,
Dasatinib,WT,Brain,0.020417379,,HPLC,15,PO,0.5,Mol Cancer Ther,2012,11,2183-2191,
Dasatinib,TKO,Brain,0.10964782,2.454708916,HPLC,15,PO,1,Mol Cancer Ther,2012,11,2183-2191,
Dasatinib,WT,Brain,0.044668359,,HPLC,15,PO,1,Mol Cancer Ther,2012,11,2183-2191,
Dasatinib,TKO,Brain,0.316227766,2.290867653,HPLC,15,PO,2,Mol Cancer Ther,2012,11,2183-2191,
Dasatinib,WT,Brain,0.138038426,,HPLC,15,PO,2,Mol Cancer Ther,2012,11,2183-2191,
Dasatinib,TKO,Brain,0.602559586,1.348962883,HPLC,15,PO,4,Mol Cancer Ther,2012,11,2183-2191,
Dasatinib,WT,Brain,0.446683592,,HPLC,15,PO,4,Mol Cancer Ther,2012,11,2183-2191,
Dasatinib,TKO,Brain,1.122018454,1.621810097,HPLC,15,PO,6,Mol Cancer Ther,2012,11,2183-2191,
Dasatinib,WT,Brain,0.691830971,,HPLC,15,PO,6,Mol Cancer Ther,2012,11,2183-2191,
Dasatinib,TKO,Brain,2.691534804,4.365158322,HPLC,15,PO,12,Mol Cancer Ther,2012,11,2183-2191,
Dasatinib,WT,Brain,0.616595002,,HPLC,15,PO,12,Mol Cancer Ther,2012,11,2183-2191,
Dexamethasone,abcb1a -/-,Brain,0.709302326,2.489795918,Radio-Labeled,0.2,IV,4,J Clin Invest,1995,96,1698-1708,
Dexamethasone,WT,Brain,0.284883721,,Radio-Labeled,0.2,IV,4,J Clin Invest,1995,96,1698-1708,
Dexamethasone,abcb1a -/-,Gall Bladder,517.3837209,1.701204359,Radio-Labeled,0.2,IV,4,J Clin Invest,1995,96,1698-1708,
Dexamethasone,WT,Gall Bladder,304.127907,,Radio-Labeled,0.2,IV,4,J Clin Invest,1995,96,1698-1708,
Dexamethasone,abcb1a -/-,Heart,0.790697674,0.772727273,Radio-Labeled,0.2,IV,4,J Clin Invest,1995,96,1698-1708,
Dexamethasone,WT,Heart,1.023255814,,Radio-Labeled,0.2,IV,4,J Clin Invest,1995,96,1698-1708,
Dexamethasone,abcb1a -/-,Kidney,2.656976744,1.202631579,Radio-Labeled,0.2,IV,4,J Clin Invest,1995,96,1698-1708,
Dexamethasone,WT,Kidney,2.209302326,,Radio-Labeled,0.2,IV,4,J Clin Invest,1995,96,1698-1708,
Dexamethasone,abcb1a -/-,Liver,52.55813953,1.097087379,Radio-Labeled,0.2,IV,4,J Clin Invest,1995,96,1698-1708,
Dexamethasone,WT,Liver,47.90697674,,Radio-Labeled,0.2,IV,4,J Clin Invest,1995,96,1698-1708,
Dexamethasone,abcb1a -/-,Lung,0.970930233,0.773148148,Radio-Labeled,0.2,IV,4,J Clin Invest,1995,96,1698-1708,
Dexamethasone,WT,Lung,1.255813953,,Radio-Labeled,0.2,IV,4,J Clin Invest,1995,96,1698-1708,
Dexamethasone,abcb1a -/-,Muscle,0.61627907,0.954954955,Radio-Labeled,0.2,IV,4,J Clin Invest,1995,96,1698-1708,
Dexamethasone,WT,Muscle,0.645348837,,Radio-Labeled,0.2,IV,4,J Clin Invest,1995,96,1698-1708,
Dexamethasone,abcb1a -/-,Spleen,0.848837209,0.941935484,Radio-Labeled,0.2,IV,4,J Clin Invest,1995,96,1698-1708,
Dexamethasone,WT,Spleen,0.901162791,,Radio-Labeled,0.2,IV,4,J Clin Invest,1995,96,1698-1708,
Dexamethasone,abcb1a -/-,Teste,0.831395349,1.222222222,Radio-Labeled,0.2,IV,4,J Clin Invest,1995,96,1698-1708,
Dexamethasone,WT,Teste,0.680232558,,Radio-Labeled,0.2,IV,4,J Clin Invest,1995,96,1698-1708,
Digoxin,abcb1a -/-,Brain,1.540111199,18.73335259,Radio-Labeled,1,IV,4,J Clin Invest,1995,96,1698-1708,
Digoxin,WT,Brain,0.082212257,,Radio-Labeled,1,IV,4,J Clin Invest,1995,96,1698-1708,
Digoxin,abcb1a -/-,Gall Bladder,43.49007149,0.925526715,Radio-Labeled,1,IV,4,J Clin Invest,1995,96,1698-1708,
Digoxin,WT,Gall Bladder,46.98953662,,Radio-Labeled,1,IV,4,J Clin Invest,1995,96,1698-1708,
Digoxin,abcb1a -/-,Heart,0.66878475,1.005431455,Radio-Labeled,1,IV,4,J Clin Invest,1995,96,1698-1708,
Digoxin,WT,Heart,0.665171898,,Radio-Labeled,1,IV,4,J Clin Invest,1995,96,1698-1708,
Digoxin,abcb1a -/-,Kidney,0.923749007,1.009784454,Radio-Labeled,1,IV,4,J Clin Invest,1995,96,1698-1708,
Digoxin,WT,Kidney,0.914798206,,Radio-Labeled,1,IV,4,J Clin Invest,1995,96,1698-1708,
Digoxin,abcb1a -/-,Liver,1.508339952,1.070073625,Radio-Labeled,1,IV,4,J Clin Invest,1995,96,1698-1708,
Digoxin,WT,Liver,1.409566517,,Radio-Labeled,1,IV,4,J Clin Invest,1995,96,1698-1708,
Digoxin,abcb1a -/-,Lung,0.617950755,1.154773896,Radio-Labeled,1,IV,4,J Clin Invest,1995,96,1698-1708,
Digoxin,WT,Lung,0.535127055,,Radio-Labeled,1,IV,4,J Clin Invest,1995,96,1698-1708,
Digoxin,abcb1a -/-,Muscle,0.868943606,0.780299695,Radio-Labeled,1,IV,4,J Clin Invest,1995,96,1698-1708,
Digoxin,WT,Muscle,1.113602392,,Radio-Labeled,1,IV,4,J Clin Invest,1995,96,1698-1708,
Digoxin,abcb1a -/-,Small Gut,1.123907863,0.592042804,Radio-Labeled,1,IV,4,J Clin Invest,1995,96,1698-1708,
Digoxin,WT,Small Gut,1.898355755,,Radio-Labeled,1,IV,4,J Clin Invest,1995,96,1698-1708,
Digoxin,abcb1a -/-,Spleen,0.390786338,1.210352131,Radio-Labeled,1,IV,4,J Clin Invest,1995,96,1698-1708,
Digoxin,WT,Spleen,0.322869955,,Radio-Labeled,1,IV,4,J Clin Invest,1995,96,1698-1708,
Digoxin,abcb1a -/-,Stomach,0.467831612,0.827987695,Radio-Labeled,1,IV,4,J Clin Invest,1995,96,1698-1708,
Digoxin,WT,Stomach,0.565022422,,Radio-Labeled,1,IV,4,J Clin Invest,1995,96,1698-1708,
Digoxin,abcb1a -/-,Teste,0.471008737,1.47936547,Radio-Labeled,1,IV,4,J Clin Invest,1995,96,1698-1708,
Digoxin,WT,Teste,0.31838565,,Radio-Labeled,1,IV,4,J Clin Invest,1995,96,1698-1708,
Digoxin,abcb1a -/-,Thymus,0.37807784,1.181934928,Radio-Labeled,1,IV,4,J Clin Invest,1995,96,1698-1708,
Digoxin,WT,Thymus,0.319880419,,Radio-Labeled,1,IV,4,J Clin Invest,1995,96,1698-1708,
Docetaxel,abcb1a/1b -/-,Brain,1.744507219,4.692211329,LC-MS,3,IV,4,J Pharmacokinet Pharmacodyn,2013,40,437-449,
Docetaxel,WT,Brain,0.371787862,,LC-MS,3,IV,4,J Pharmacokinet Pharmacodyn,2013,40,437-449,
Docetaxel,abcb1a/1b -/-,Heart,41.01464742,1.477609864,LC-MS,3,IV,4,J Pharmacokinet Pharmacodyn,2013,40,437-449,
Docetaxel,WT,Heart,27.75742664,,LC-MS,3,IV,4,J Pharmacokinet Pharmacodyn,2013,40,437-449,
Docetaxel,abcb1a/1b -/-,Kidney,47.61958569,1.713278429,LC-MS,3,IV,4,J Pharmacokinet Pharmacodyn,2013,40,437-449,
Docetaxel,WT,Kidney,27.79442318,,LC-MS,3,IV,4,J Pharmacokinet Pharmacodyn,2013,40,437-449,
Docetaxel,abcb1a/1b -/-,Liver,11.02050638,1.193469487,LC-MS,3,IV,4,J Pharmacokinet Pharmacodyn,2013,40,437-449,
Docetaxel,WT,Liver,9.234007654,,LC-MS,3,IV,4,J Pharmacokinet Pharmacodyn,2013,40,437-449,
Docetaxel,abcb1a/1b -/-,Lung,100.7752668,3.061726276,LC-MS,3,IV,4,J Pharmacokinet Pharmacodyn,2013,40,437-449,
Docetaxel,WT,Lung,32.91452524,,LC-MS,3,IV,4,J Pharmacokinet Pharmacodyn,2013,40,437-449,
Docetaxel,abcb1a/1b -/-,Small Gut,16.21552626,2.75787591,LC-MS,3,IV,4,J Pharmacokinet Pharmacodyn,2013,40,437-449,
Docetaxel,WT,Small Gut,5.879715692,,LC-MS,3,IV,4,J Pharmacokinet Pharmacodyn,2013,40,437-449,
Doxorubicin,abcb1a -/-,Brain,0.00254545,0.330908831,HPLC,5,IV,1,Br J Cancer,1999,79,108-115,
Doxorubicin,WT,Brain,0.0076923,,HPLC,5,IV,1,Br J Cancer,1999,79,108-115,
Doxorubicin,abcb1a -/-,Brain,0.00498489,2.90784523,HPLC,5,IV,4,Br J Cancer,1999,79,108-115,
Doxorubicin,WT,Brain,0.00171429,,HPLC,5,IV,4,Br J Cancer,1999,79,108-115,
Doxorubicin,abcb1a -/-,Brain,0.00744681,2.023050927,HPLC,5,IV,24,Br J Cancer,1999,79,108-115,
Doxorubicin,WT,Brain,0.00368098,,HPLC,5,IV,24,Br J Cancer,1999,79,108-115,
Doxorubicin,abcb1a -/-,Breast,0.058727273,1.337048241,HPLC,5,IV,1,Br J Cancer,1999,79,108-115,
Doxorubicin,WT,Breast,0.043923077,,HPLC,5,IV,1,Br J Cancer,1999,79,108-115,
Doxorubicin,abcb1a -/-,Breast,0.107401813,1.768971033,HPLC,5,IV,4,Br J Cancer,1999,79,108-115,
Doxorubicin,WT,Breast,0.060714286,,HPLC,5,IV,4,Br J Cancer,1999,79,108-115,
Doxorubicin,abcb1a -/-,Breast,0.192198582,2.131181551,HPLC,5,IV,24,Br J Cancer,1999,79,108-115,
Doxorubicin,WT,Breast,0.090184049,,HPLC,5,IV,24,Br J Cancer,1999,79,108-115,
Doxorubicin,abcb1a -/-,Caecum,0.087636364,1.433047456,HPLC,5,IV,1,Br J Cancer,1999,79,108-115,
Doxorubicin,WT,Caecum,0.061153846,,HPLC,5,IV,1,Br J Cancer,1999,79,108-115,
Doxorubicin,abcb1a -/-,Caecum,0.170694864,1.214292732,HPLC,5,IV,4,Br J Cancer,1999,79,108-115,
Doxorubicin,WT,Caecum,0.140571429,,HPLC,5,IV,4,Br J Cancer,1999,79,108-115,
Doxorubicin,abcb1a -/-,Caecum,0.246808511,1.431665026,HPLC,5,IV,24,Br J Cancer,1999,79,108-115,
Doxorubicin,WT,Caecum,0.172392638,,HPLC,5,IV,24,Br J Cancer,1999,79,108-115,
Doxorubicin,abcb1a -/-,Colon,0.087727273,1.395905196,HPLC,5,IV,1,Br J Cancer,1999,79,108-115,
Doxorubicin,WT,Colon,0.062846154,,HPLC,5,IV,1,Br J Cancer,1999,79,108-115,
Doxorubicin,abcb1a -/-,Colon,0.190332326,1.024866372,HPLC,5,IV,4,Br J Cancer,1999,79,108-115,
Doxorubicin,WT,Colon,0.185714286,,HPLC,5,IV,4,Br J Cancer,1999,79,108-115,
Doxorubicin,abcb1a -/-,Colon,0.273049645,1.488531512,HPLC,5,IV,24,Br J Cancer,1999,79,108-115,
Doxorubicin,WT,Colon,0.183435583,,HPLC,5,IV,24,Br J Cancer,1999,79,108-115,
Doxorubicin,abcb1a -/-,Heart,0.214545455,1.297251586,HPLC,5,IV,1,Br J Cancer,1999,79,108-115,
Doxorubicin,WT,Heart,0.165384615,,HPLC,5,IV,1,Br J Cancer,1999,79,108-115,
Doxorubicin,abcb1a -/-,Heart,0.20694864,1.149714669,HPLC,5,IV,4,Br J Cancer,1999,79,108-115,
Doxorubicin,WT,Heart,0.18,,HPLC,5,IV,4,Br J Cancer,1999,79,108-115,
Doxorubicin,abcb1a -/-,Heart,0.168085106,1.621175878,HPLC,5,IV,24,Br J Cancer,1999,79,108-115,
Doxorubicin,WT,Heart,0.103680982,,HPLC,5,IV,24,Br J Cancer,1999,79,108-115,
Doxorubicin,abcb1a -/-,Kidney,0.301818182,1.083877449,HPLC,5,IV,1,Br J Cancer,1999,79,108-115,
Doxorubicin,WT,Kidney,0.278461538,,HPLC,5,IV,1,Br J Cancer,1999,79,108-115,
Doxorubicin,abcb1a -/-,Kidney,0.326283988,1.024209828,HPLC,5,IV,4,Br J Cancer,1999,79,108-115,
Doxorubicin,WT,Kidney,0.318571429,,HPLC,5,IV,4,Br J Cancer,1999,79,108-115,
Doxorubicin,abcb1a -/-,Kidney,0.320921986,0.920955699,HPLC,5,IV,24,Br J Cancer,1999,79,108-115,
Doxorubicin,WT,Kidney,0.348466258,,HPLC,5,IV,24,Br J Cancer,1999,79,108-115,
Doxorubicin,abcb1a -/-,Liver,0.406363636,2.564430715,HPLC,5,IV,1,Br J Cancer,1999,79,108-115,
Doxorubicin,WT,Liver,0.158461538,,HPLC,5,IV,1,Br J Cancer,1999,79,108-115,
Doxorubicin,abcb1a -/-,Liver,0.68429003,4.69610805,HPLC,5,IV,4,Br J Cancer,1999,79,108-115,
Doxorubicin,WT,Liver,0.145714286,,HPLC,5,IV,4,Br J Cancer,1999,79,108-115,
Doxorubicin,abcb1a -/-,Liver,0.482269504,4.651475093,HPLC,5,IV,24,Br J Cancer,1999,79,108-115,
Doxorubicin,WT,Liver,0.103680982,,HPLC,5,IV,24,Br J Cancer,1999,79,108-115,
Doxorubicin,abcb1a -/-,Lung,0.23,1.283261803,HPLC,5,IV,1,Br J Cancer,1999,79,108-115,
Doxorubicin,WT,Lung,0.179230769,,HPLC,5,IV,1,Br J Cancer,1999,79,108-115,
Doxorubicin,abcb1a -/-,Lung,0.370090634,1.107108736,HPLC,5,IV,4,Br J Cancer,1999,79,108-115,
Doxorubicin,WT,Lung,0.334285714,,HPLC,5,IV,4,Br J Cancer,1999,79,108-115,
Doxorubicin,abcb1a -/-,Lung,0.670212766,2.163261007,HPLC,5,IV,24,Br J Cancer,1999,79,108-115,
Doxorubicin,WT,Lung,0.309815951,,HPLC,5,IV,24,Br J Cancer,1999,79,108-115,
Doxorubicin,abcb1a -/-,Muscle,0.054818182,1.025376063,HPLC,5,IV,1,Br J Cancer,1999,79,108-115,
Doxorubicin,WT,Muscle,0.053461538,,HPLC,5,IV,1,Br J Cancer,1999,79,108-115,
Doxorubicin,abcb1a -/-,Muscle,0.09939577,0.878497971,HPLC,5,IV,4,Br J Cancer,1999,79,108-115,
Doxorubicin,WT,Muscle,0.113142857,,HPLC,5,IV,4,Br J Cancer,1999,79,108-115,
Doxorubicin,abcb1a -/-,Muscle,0.066666667,0.804938272,HPLC,5,IV,24,Br J Cancer,1999,79,108-115,
Doxorubicin,WT,Muscle,0.082822086,,HPLC,5,IV,24,Br J Cancer,1999,79,108-115,
Doxorubicin,abcb1a -/-,Ovary,0.087,1.526315789,HPLC,5,IV,1,Br J Cancer,1999,79,108-115,
Doxorubicin,WT,Ovary,0.057,,HPLC,5,IV,1,Br J Cancer,1999,79,108-115,
Doxorubicin,abcb1a -/-,Ovary,0.138,1.4375,HPLC,5,IV,4,Br J Cancer,1999,79,108-115,
Doxorubicin,WT,Ovary,0.096,,HPLC,5,IV,4,Br J Cancer,1999,79,108-115,
Doxorubicin,abcb1a -/-,Ovary,0.207,0.70890411,HPLC,5,IV,24,Br J Cancer,1999,79,108-115,
Doxorubicin,WT,Ovary,0.292,,HPLC,5,IV,24,Br J Cancer,1999,79,108-115,
Doxorubicin,abcb1a -/-,Small Gut,0.159090909,1.456466069,HPLC,5,IV,1,Br J Cancer,1999,79,108-115,
Doxorubicin,WT,Small Gut,0.109230769,,HPLC,5,IV,1,Br J Cancer,1999,79,108-115,
Doxorubicin,abcb1a -/-,Small Gut,0.282477341,1.354343418,HPLC,5,IV,4,Br J Cancer,1999,79,108-115,
Doxorubicin,WT,Small Gut,0.208571429,,HPLC,5,IV,4,Br J Cancer,1999,79,108-115,
Doxorubicin,abcb1a -/-,Small Gut,0.460992908,2.110725954,HPLC,5,IV,24,Br J Cancer,1999,79,108-115,
Doxorubicin,WT,Small Gut,0.218404908,,HPLC,5,IV,24,Br J Cancer,1999,79,108-115,
Doxorubicin,abcb1a -/-,Spleen,0.171818182,1.345564074,HPLC,5,IV,1,Br J Cancer,1999,79,108-115,
Doxorubicin,WT,Spleen,0.127692308,,HPLC,5,IV,1,Br J Cancer,1999,79,108-115,
Doxorubicin,abcb1a -/-,Spleen,0.339879154,1.00386248,HPLC,5,IV,4,Br J Cancer,1999,79,108-115,
Doxorubicin,WT,Spleen,0.338571429,,HPLC,5,IV,4,Br J Cancer,1999,79,108-115,
Doxorubicin,abcb1a -/-,Spleen,1.035460993,1.016747842,HPLC,5,IV,24,Br J Cancer,1999,79,108-115,
Doxorubicin,WT,Spleen,1.018404908,,HPLC,5,IV,24,Br J Cancer,1999,79,108-115,
Doxorubicin,abcb1a -/-,Stomach,0.065545455,1.109493371,HPLC,5,IV,1,Br J Cancer,1999,79,108-115,
Doxorubicin,WT,Stomach,0.059076923,,HPLC,5,IV,1,Br J Cancer,1999,79,108-115,
Doxorubicin,abcb1a -/-,Stomach,0.16918429,1.600391933,HPLC,5,IV,4,Br J Cancer,1999,79,108-115,
Doxorubicin,WT,Stomach,0.105714286,,HPLC,5,IV,4,Br J Cancer,1999,79,108-115,
Doxorubicin,abcb1a -/-,Stomach,0.206382979,1.035090016,HPLC,5,IV,24,Br J Cancer,1999,79,108-115,
Doxorubicin,WT,Stomach,0.199386503,,HPLC,5,IV,24,Br J Cancer,1999,79,108-115,
Doxorubicin,abcb1a -/-,Uterus,0.096363636,1.569833675,HPLC,5,IV,1,Br J Cancer,1999,79,108-115,
Doxorubicin,WT,Uterus,0.061384615,,HPLC,5,IV,1,Br J Cancer,1999,79,108-115,
Doxorubicin,abcb1a -/-,Uterus,0.121903323,0.705225837,HPLC,5,IV,4,Br J Cancer,1999,79,108-115,
Doxorubicin,WT,Uterus,0.172857143,,HPLC,5,IV,4,Br J Cancer,1999,79,108-115,
Doxorubicin,abcb1a -/-,Uterus,0.457446809,1.099761501,HPLC,5,IV,24,Br J Cancer,1999,79,108-115,
Doxorubicin,WT,Uterus,0.41595092,,HPLC,5,IV,24,Br J Cancer,1999,79,108-115,
Elacridar,abcb1a/1b -/-,Brain,1.3111194,4.240121812,LC-MS,2.5,IV,8,J Pharmacol Exp Ther,2013,345,111-124,
Elacridar,abcg2 -/-,Brain,2.773956044,8.970892756,LC-MS,2.5,IV,8,J Pharmacol Exp Ther,2013,345,111-124,
Elacridar,TKO,Brain,6.81044706,22.0247867,LC-MS,2.5,IV,8,J Pharmacol Exp Ther,2013,345,111-124,
Elacridar,WT,Brain,0.30921739,,LC-MS,2.5,IV,8,J Pharmacol Exp Ther,2013,345,111-124,
Etoposide, abcc1 -/-; abcb1a/1b -/-; ,Brain,0.24929972,,Radio-Labeled,1,IV,4,J Clin Invest,2000,105,279-285,
Etoposide,abcb1a/1b -/-,Brain,0.233802817,,Radio-Labeled,1,IV,4,J Clin Invest,2000,105,279-285,
Etoposide,abcb1a/1b -/-,Caecum,22.49859155,,Radio-Labeled,1,IV,4,J Clin Invest,2000,105,279-285,
Etoposide, abcc1 -/-; abcb1a/1b -/-; ,Caecum,18.84593838,,Radio-Labeled,1,IV,4,J Clin Invest,2000,105,279-285,
Etoposide,abcb1a/1b -/-,Colon,5.416901408,,Radio-Labeled,1,IV,4,J Clin Invest,2000,105,279-285,
Etoposide, abcc1 -/-; abcb1a/1b -/-; ,Colon,12.12885154,,Radio-Labeled,1,IV,4,J Clin Invest,2000,105,279-285,
Etoposide,abcb1a/1b -/-,Gall Bladder,648.8647887,,Radio-Labeled,1,IV,4,J Clin Invest,2000,105,279-285,
Etoposide, abcc1 -/-; abcb1a/1b -/-; ,Gall Bladder,363.3977591,,Radio-Labeled,1,IV,4,J Clin Invest,2000,105,279-285,
Etoposide,abcb1a/1b -/-,Heart,0.23943662,,Radio-Labeled,1,IV,4,J Clin Invest,2000,105,279-285,
Etoposide, abcc1 -/-; abcb1a/1b -/-; ,Heart,0.316526611,,Radio-Labeled,1,IV,4,J Clin Invest,2000,105,279-285,
Etoposide,abcb1a/1b -/-,Kidney,0.433802817,,Radio-Labeled,1,IV,4,J Clin Invest,2000,105,279-285,
Etoposide, abcc1 -/-; abcb1a/1b -/-; ,Kidney,0.467787115,,Radio-Labeled,1,IV,4,J Clin Invest,2000,105,279-285,
Etoposide, abcc1 -/-; abcb1a/1b -/-; ,Liver,1.106442577,,Radio-Labeled,1,IV,4,J Clin Invest,2000,105,279-285,
Etoposide,abcb1a/1b -/-,Liver,0.712676056,,Radio-Labeled,1,IV,4,J Clin Invest,2000,105,279-285,
Etoposide, abcc1 -/-; abcb1a/1b -/-; ,Lung,0.400560224,,Radio-Labeled,1,IV,4,J Clin Invest,2000,105,279-285,
Etoposide,abcb1a/1b -/-,Lung,0.354929577,,Radio-Labeled,1,IV,4,J Clin Invest,2000,105,279-285,
Etoposide, abcc1 -/-; abcb1a/1b -/-; ,Muscle,0.294117647,,Radio-Labeled,1,IV,4,J Clin Invest,2000,105,279-285,
Etoposide,abcb1a/1b -/-,Muscle,0.270422535,,Radio-Labeled,1,IV,4,J Clin Invest,2000,105,279-285,
Etoposide, abcc1 -/-; abcb1a/1b -/-; ,Small Gut,8.224089636,,Radio-Labeled,1,IV,4,J Clin Invest,2000,105,279-285,
Etoposide,abcb1a/1b -/-,Small Gut,4.94084507,,Radio-Labeled,1,IV,4,J Clin Invest,2000,105,279-285,
Etoposide, abcc1 -/-; abcb1a/1b -/-; ,Stomach,0.638655462,,Radio-Labeled,1,IV,4,J Clin Invest,2000,105,279-285,
Etoposide,abcb1a/1b -/-,Stomach,0.552112676,,Radio-Labeled,1,IV,4,J Clin Invest,2000,105,279-285,
Etoposide, abcc1 -/-; abcb1a/1b -/-; ,Thymus,0.246498599,,Radio-Labeled,1,IV,4,J Clin Invest,2000,105,279-285,
Etoposide,abcb1a/1b -/-,Thymus,0.233802817,,Radio-Labeled,1,IV,4,J Clin Invest,2000,105,279-285,
Everolimus,abcb1a/1b -/-,Brain,0.384443928,0.4759886,LC-MS,2,IV,1,Clin Cancer Res,2014,20,3133-3145,
Everolimus,abcg2 -/-,Brain,0.043584904,0.539634,LC-MS,2,IV,1,Clin Cancer Res,2014,20,3133-3145,
Everolimus,TKO,Brain,0.422535606,0.5231507,LC-MS,2,IV,1,Clin Cancer Res,2014,20,3133-3145,
Everolimus,WT,Brain,0.807674667,,LC-MS,2,IV,1,Clin Cancer Res,2014,20,3133-3145,
Everolimus,abcb1a/1b -/-,Liver,0.948395721,0.04209,LC-MS,2,IV,1,Clin Cancer Res,2014,20,3133-3145,
Everolimus,WT,Liver,22.44784182,,LC-MS,2,IV,1,Clin Cancer Res,2014,20,3133-3145,
Everolimus,abcg2 -/-,Liver,0.944828928,0.0422489,LC-MS,2,IV,1,Clin Cancer Res,2014,20,3133-3145,
Everolimus,TKO,Liver,0.990180679,0.0441103,LC-MS,2,IV,1,Clin Cancer Res,2014,20,3133-3145,
Fisogatinib,abcb1a/1b -/-,Brain,0.7,5.833333333,LC-MS,10,PO,1,International Journal of Pharmaceutics,2020,573,118842,
Fisogatinib,abcg2 -/-,Brain,0.13,1.083333333,LC-MS,10,PO,1,International Journal of Pharmaceutics,2020,573,118842,
Fisogatinib,TKO,Brain,0.83,6.916666667,LC-MS,10,PO,1,International Journal of Pharmaceutics,2020,573,118842,
Fisogatinib,WT,Brain,0.12,,LC-MS,10,PO,1,International Journal of Pharmaceutics,2020,573,118842,
Fisogatinib,abcb1a/1b -/-,Liver,3.63,0.881067961,LC-MS,10,PO,1,International Journal of Pharmaceutics,2020,573,118842,
Fisogatinib,WT,Liver,4.12,,LC-MS,10,PO,1,International Journal of Pharmaceutics,2020,573,118842,
Fisogatinib,abcg2 -/-,Liver,3.92,0.951456311,LC-MS,10,PO,1,International Journal of Pharmaceutics,2020,573,118842,
Fisogatinib,TKO,Liver,4.5,1.09223301,LC-MS,10,PO,1,International Journal of Pharmaceutics,2020,573,118842,
Fisogatinib,abcg2 -/-,Teste,0.49,0.890909091,LC-MS,10,PO,1,International Journal of Pharmaceutics,2020,573,118842,
Fisogatinib,TKO,Teste,1.6,2.909090909,LC-MS,10,PO,1,International Journal of Pharmaceutics,2020,573,118842,
Fisogatinib,abcb1a/1b -/-,Teste,1.2,2.181818182,LC-MS,10,PO,1,International Journal of Pharmaceutics,2020,573,118842,
Fisogatinib,WT,Teste,0.55,,LC-MS,10,PO,1,International Journal of Pharmaceutics,2020,573,118842,
Flavopiridol,abcb1a/1b -/-,Brain,0.71,1.69047619,LC-MS,5,SQ,0.5,Drug Metab Dispos,2009,37,946-955,
Flavopiridol,abcg2 -/-,Brain,0.55,1.30952381,LC-MS,5,SQ,0.5,Drug Metab Dispos,2009,37,946-955,
Flavopiridol,TKO,Brain,3.11,7.404761905,LC-MS,5,SQ,0.5,Drug Metab Dispos,2009,37,946-955,
Flavopiridol,WT,Brain,0.42,,LC-MS,5,SQ,0.5,Drug Metab Dispos,2009,37,946-955,
Flavopiridol,abcb1a/1b -/-,Brain,1.45,1.576086957,LC-MS,5,SQ,2,Drug Metab Dispos,2009,37,946-955,
Flavopiridol,abcg2 -/-,Brain,1.22,1.326086957,LC-MS,5,SQ,2,Drug Metab Dispos,2009,37,946-955,
Flavopiridol,TKO,Brain,6.34,6.891304348,LC-MS,5,SQ,2,Drug Metab Dispos,2009,37,946-955,
Flavopiridol,WT,Brain,0.92,,LC-MS,5,SQ,2,Drug Metab Dispos,2009,37,946-955,
Galunisertib,abcb1a/1b -/-,Brain,1,24.3902439,LC-MS,20,PO,1,International Journal of Cancer,2020,146,1631-1642,
Galunisertib,abcg2 -/-,Brain,0.051,1.243902439,LC-MS,20,PO,1,International Journal of Cancer,2020,146,1631-1642,
Galunisertib,cyp3a -/-,Brain,0.053,1.292682927,LC-MS,20,PO,1,International Journal of Cancer,2020,146,1631-1642,
Galunisertib,cyp3aXAV,Brain,0.035,0.853658537,LC-MS,20,PO,1,International Journal of Cancer,2020,146,1631-1642,
Galunisertib,TKO,Brain,0.97,23.65853659,LC-MS,20,PO,1,International Journal of Cancer,2020,146,1631-1642,
Galunisertib,WT,Brain,0.041,,LC-MS,20,PO,1,International Journal of Cancer,2020,146,1631-1642,
Galunisertib,abcb1a/1b -/-,Liver,3.8,1,LC-MS,20,PO,1,International Journal of Cancer,2020,146,1631-1642,
Galunisertib,WT,Liver,3.8,,LC-MS,20,PO,1,International Journal of Cancer,2020,146,1631-1642,
Galunisertib,abcg2 -/-,Liver,3.9,1.026315789,LC-MS,20,PO,1,International Journal of Cancer,2020,146,1631-1642,
Galunisertib,cyp3a -/-,Liver,3.3,0.868421053,LC-MS,20,PO,1,International Journal of Cancer,2020,146,1631-1642,
Galunisertib,cyp3aXAV,Liver,3.2,0.842105263,LC-MS,20,PO,1,International Journal of Cancer,2020,146,1631-1642,
Galunisertib,TKO,Liver,3.1,0.815789474,LC-MS,20,PO,1,International Journal of Cancer,2020,146,1631-1642,
Galunisertib,abcg2 -/-,Small Gut,5.016667,0.729803171,LC-MS,20,PO,1,International Journal of Cancer,2020,146,1631-1642,
Galunisertib,cyp3a -/-,Small Gut,5.33561484,0.776202333,LC-MS,20,PO,1,International Journal of Cancer,2020,146,1631-1642,
Galunisertib,cyp3aXAV,Small Gut,4.56342845,0.663867974,LC-MS,20,PO,1,International Journal of Cancer,2020,146,1631-1642,
Galunisertib,TKO,Small Gut,0.81737221,0.118907799,LC-MS,20,PO,1,International Journal of Cancer,2020,146,1631-1642,
Galunisertib,abcb1a/1b -/-,Small Gut,0.49644,0.072219959,LC-MS,20,PO,1,International Journal of Cancer,2020,146,1631-1642,
Galunisertib,WT,Small Gut,6.874,,LC-MS,20,PO,1,International Journal of Cancer,2020,146,1631-1642,
Gimatecan,abcb1a/1b -/-,Brain,0.45,1.875,HPLC,2,IV,1,Clin Cancer Res,2013,19,2084-2095,
Gimatecan,abcc4 -/-,Brain,0.2,0.833333333,HPLC,2,IV,1,Clin Cancer Res,2013,19,2084-2095,
Gimatecan,abcc4 -/-; abcg2 -/-,Brain,0.3,1.25,HPLC,2,IV,1,Clin Cancer Res,2013,19,2084-2095,
Gimatecan,abcc4 -/-; abcg2 -/-; abcb1a/1b -/-,Brain,0.83,3.458333333,HPLC,2,IV,1,Clin Cancer Res,2013,19,2084-2095,
Gimatecan,abcg2 -/-,Brain,0.35,1.458333333,HPLC,2,IV,1,Clin Cancer Res,2013,19,2084-2095,
Gimatecan,TKO,Brain,0.63,2.625,HPLC,2,IV,1,Clin Cancer Res,2013,19,2084-2095,
Gimatecan,WT,Brain,0.24,,HPLC,2,IV,1,Clin Cancer Res,2013,19,2084-2095,
Gimatecan,abcb1a/1b -/-,Brain,0.66,2.129032258,HPLC,2,IV,4,Clin Cancer Res,2013,19,2084-2095,
Gimatecan,abcc4 -/-,Brain,0.34,1.096774194,HPLC,2,IV,4,Clin Cancer Res,2013,19,2084-2095,
Gimatecan,abcc4 -/-; abcg2 -/-,Brain,0.54,1.741935484,HPLC,2,IV,4,Clin Cancer Res,2013,19,2084-2095,
Gimatecan,abcc4 -/-; abcg2 -/-; abcb1a/1b -/-,Brain,1.25,4.032258065,HPLC,2,IV,4,Clin Cancer Res,2013,19,2084-2095,
Gimatecan,abcg2 -/-,Brain,0.48,1.548387097,HPLC,2,IV,4,Clin Cancer Res,2013,19,2084-2095,
Gimatecan,TKO,Brain,0.84,2.709677419,HPLC,2,IV,4,Clin Cancer Res,2013,19,2084-2095,
Gimatecan,WT,Brain,0.31,,HPLC,2,IV,4,Clin Cancer Res,2013,19,2084-2095,
Ibrutinib,abcb1a/1b -/-,Brain,0.04021978,3.3689133,LC-MS,10,PO,1,Mol Pharmaceuticals,2018,15,5124-5134,
Ibrutinib,abcg2 -/-,Brain,0.01252996,1.049542,LC-MS,10,PO,1,Mol Pharmaceuticals,2018,15,5124-5134,
Ibrutinib,cyp3a-/-,Brain,0.033585477,2.8132068,LC-MS,10,PO,1,Mol Pharmaceuticals,2018,15,5124-5134,
Ibrutinib,TKO,Brain,0.069623656,5.8318583,LC-MS,10,PO,1,Mol Pharmaceuticals,2018,15,5124-5134,
Ibrutinib,WT,Brain,0.011938503,,LC-MS,10,PO,1,Mol Pharmaceuticals,2018,15,5124-5134,
Ibrutinib,abcb1a/1b -/-,Liver,0.119340659,0.5510297,LC-MS,10,PO,1,Mol Pharmaceuticals,2018,15,5124-5134,
Ibrutinib,WT,Liver,0.21657754,,LC-MS,10,PO,1,Mol Pharmaceuticals,2018,15,5124-5134,
Ibrutinib,abcg2 -/-,Liver,0.202396804,0.9345235,LC-MS,10,PO,1,Mol Pharmaceuticals,2018,15,5124-5134,
Ibrutinib,cyp3a-/-,Liver,0.428139183,1.9768402,LC-MS,10,PO,1,Mol Pharmaceuticals,2018,15,5124-5134,
Ibrutinib,TKO,Liver,0.206989247,0.9557281,LC-MS,10,PO,1,Mol Pharmaceuticals,2018,15,5124-5134,
Imatinib,abcb1a/1b -/-,Brain,0.09,4.5,LC-MS,5,SQ,0.5,Drug Metab Dispos,2009,37,946-957,
Imatinib,abcg2 -/-,Brain,0.02,1,LC-MS,5,SQ,0.5,Drug Metab Dispos,2009,37,946-957,
Imatinib,TKO,Brain,0.58,29,LC-MS,5,SQ,0.5,Drug Metab Dispos,2009,37,946-957,
Imatinib,WT,Brain,0.02,,LC-MS,5,SQ,0.5,Drug Metab Dispos,2009,37,946-957,
Imatinib,abcb1a/1b -/-,Brain,0.06,2,HPLC,100,PO,1,Investigational New Drugs,2009,27,31-40,
Imatinib,abcg2 -/-,Brain,0.01,0.3333,HPLC,100,PO,1,Investigational New Drugs,2009,27,31-40,
Imatinib,TKO,Brain,0.31,10.3333,HPLC,100,PO,1,Investigational New Drugs,2009,27,31-40,
Imatinib,WT,Brain,0.03,,HPLC,100,PO,1,Investigational New Drugs,2009,27,31-40,
Imatinib,abcb1a/1b -/-,Brain,0.11,5.5,LC-MS,5,SQ,2,Drug Metab Dispos,2009,37,946-957,
Imatinib,abcg2 -/-,Brain,0.02,1,LC-MS,5,SQ,2,Drug Metab Dispos,2009,37,946-957,
Imatinib,TKO,Brain,1.55,77.5,LC-MS,5,SQ,2,Drug Metab Dispos,2009,37,946-957,
Imatinib,WT,Brain,0.02,,LC-MS,5,SQ,2,Drug Metab Dispos,2009,37,946-957,
Imatinib,abcb1a/1b -/-,Brain,0.08,1.14285714,HPLC,100,PO,4,Investigational New Drugs,2009,27,31-40,
Imatinib,abcg2 -/-,Brain,0.02,0.28571429,HPLC,100,PO,4,Investigational New Drugs,2009,27,31-40,
Imatinib,TKO,Brain,1.24,17.7142857,HPLC,100,PO,4,Investigational New Drugs,2009,27,31-40,
Imatinib,WT,Brain,0.07,,HPLC,100,PO,4,Investigational New Drugs,2009,27,31-40,
Imatinib,abcb1a/1b -/-,Kidney,0.98,0.95145631,HPLC,100,PO,1,Investigational New Drugs,2009,27,31-40,
Imatinib,WT,Kidney,1.03,,HPLC,100,PO,1,Investigational New Drugs,2009,27,31-40,
Imatinib,abcb1a/1b -/-,Kidney,1.25,0.78125,HPLC,100,PO,4,Investigational New Drugs,2009,27,31-40,
Imatinib,WT,Kidney,1.6,,HPLC,100,PO,4,Investigational New Drugs,2009,27,31-40,
Imatinib,abcg2 -/-,Kidney,1.18,1.14563107,HPLC,100,PO,1,Investigational New Drugs,2009,27,31-40,
Imatinib,TKO,Kidney,0.98,0.95145631,HPLC,100,PO,1,Investigational New Drugs,2009,27,31-40,
Imatinib,abcg2 -/-,Kidney,1.28,0.8,HPLC,100,PO,4,Investigational New Drugs,2009,27,31-40,
Imatinib,TKO,Kidney,1.68,1.05,HPLC,100,PO,4,Investigational New Drugs,2009,27,31-40,
Imatinib,abcb1a/1b -/-,Liver,1.42,1.03649635,HPLC,100,PO,1,Investigational New Drugs,2009,27,31-40,
Imatinib,WT,Liver,1.37,,HPLC,100,PO,1,Investigational New Drugs,2009,27,31-40,
Imatinib,abcb1a/1b -/-,Liver,1.92,1.07865169,HPLC,100,PO,4,Investigational New Drugs,2009,27,31-40,
Imatinib,WT,Liver,1.78,,HPLC,100,PO,4,Investigational New Drugs,2009,27,31-40,
Imatinib,abcg2 -/-,Liver,1.9,1.38686131,HPLC,100,PO,1,Investigational New Drugs,2009,27,31-40,
Imatinib,TKO,Liver,2,1.45985401,HPLC,100,PO,1,Investigational New Drugs,2009,27,31-40,
Imatinib,abcg2 -/-,Liver,2.15,1.20786517,HPLC,100,PO,4,Investigational New Drugs,2009,27,31-40,
Imatinib,TKO,Liver,3.01,1.69101124,HPLC,100,PO,4,Investigational New Drugs,2009,27,31-40,
Irinotecan,abcc4 -/-; abcg2 -/-; abcb1a/1b -/-,Brain,16.91,61.49090909,HPLC,5,IV,1,Clin Cancer Res,2013,19,2084-2095,
Irinotecan,abcg2 -/-,Brain,2.82,10.25454545,HPLC,5,IV,1,Clin Cancer Res,2013,19,2084-2095,
Irinotecan,TKO,Brain,9.611,34.94909091,HPLC,5,IV,1,Clin Cancer Res,2013,19,2084-2095,
Irinotecan,WT,Brain,0.275,,HPLC,5,IV,1,Clin Cancer Res,2013,19,2084-2095,
Irinotecan,abcc4 -/-; abcg2 -/-; abcb1a/1b -/-,Brain,219.55,73.18333333,HPLC,5,IV,4,Clin Cancer Res,2013,19,2084-2095,
Irinotecan,abcg2 -/-,Brain,8.78,2.926666667,HPLC,5,IV,4,Clin Cancer Res,2013,19,2084-2095,
Irinotecan,TKO,Brain,197.74,65.91333333,HPLC,5,IV,4,Clin Cancer Res,2013,19,2084-2095,
Irinotecan,WT,Brain,3,,HPLC,5,IV,4,Clin Cancer Res,2013,19,2084-2095,
Ivermectin,abcb1a -/-,Brain,2.51923077,26.87179488,Radio-Labeled,0.02,PO,24,Adv Drug Deliv Rev,1999,36,179-194,
Ivermectin,WT,Brain,0.09375,,Radio-Labeled,0.02,PO,24,Adv Drug Deliv Rev,1999,36,179-194,
Ivermectin,abcb1a -/-,Colon,2.076923077,1.071960298,Radio-Labeled,0.02,PO,24,Adv Drug Deliv Rev,1999,36,179-194,
Ivermectin,WT,Colon,1.9375,,Radio-Labeled,0.02,PO,24,Adv Drug Deliv Rev,1999,36,179-194,
Ivermectin,abcb1a -/-,Epododumis,3.153846154,0.855280313,Radio-Labeled,0.02,PO,24,Adv Drug Deliv Rev,1999,36,179-194,
Ivermectin,WT,Epododumis,3.6875,,Radio-Labeled,0.02,PO,24,Adv Drug Deliv Rev,1999,36,179-194,
Ivermectin,abcb1a -/-,Fat (neck),9.346153846,0.795417349,Radio-Labeled,0.02,PO,24,Adv Drug Deliv Rev,1999,36,179-194,
Ivermectin,WT,Fat (neck),11.75,,Radio-Labeled,0.02,PO,24,Adv Drug Deliv Rev,1999,36,179-194,
Ivermectin,abcb1a -/-,Fat (organ),2.923076923,0.371184371,Radio-Labeled,0.02,PO,24,Adv Drug Deliv Rev,1999,36,179-194,
Ivermectin,WT,Fat (organ),7.875,,Radio-Labeled,0.02,PO,24,Adv Drug Deliv Rev,1999,36,179-194,
Ivermectin,abcb1a -/-,Gall Bladder,26.46153846,2.880167452,Radio-Labeled,0.02,PO,24,Adv Drug Deliv Rev,1999,36,179-194,
Ivermectin,WT,Gall Bladder,9.1875,,Radio-Labeled,0.02,PO,24,Adv Drug Deliv Rev,1999,36,179-194,
Ivermectin,abcb1a -/-,Heart,1.923076923,1.230769231,Radio-Labeled,0.02,PO,24,Adv Drug Deliv Rev,1999,36,179-194,
Ivermectin,WT,Heart,1.5625,,Radio-Labeled,0.02,PO,24,Adv Drug Deliv Rev,1999,36,179-194,
Ivermectin,abcb1a -/-,Kidney,2.711538462,0.923076923,Radio-Labeled,0.02,PO,24,Adv Drug Deliv Rev,1999,36,179-194,
Ivermectin,WT,Kidney,2.9375,,Radio-Labeled,0.02,PO,24,Adv Drug Deliv Rev,1999,36,179-194,
Ivermectin,abcb1a -/-,Liver,9.557692308,1.176331361,Radio-Labeled,0.02,PO,24,Adv Drug Deliv Rev,1999,36,179-194,
Ivermectin,WT,Liver,8.125,,Radio-Labeled,0.02,PO,24,Adv Drug Deliv Rev,1999,36,179-194,
Ivermectin,abcb1a -/-,Lung,1.75,1.217391304,Radio-Labeled,0.02,PO,24,Adv Drug Deliv Rev,1999,36,179-194,
Ivermectin,WT,Lung,1.4375,,Radio-Labeled,0.02,PO,24,Adv Drug Deliv Rev,1999,36,179-194,
Ivermectin,abcb1a -/-,Muscle,0.923076923,1.538461538,Radio-Labeled,0.02,PO,24,Adv Drug Deliv Rev,1999,36,179-194,
Ivermectin,WT,Muscle,0.6,,Radio-Labeled,0.02,PO,24,Adv Drug Deliv Rev,1999,36,179-194,
Ivermectin,abcb1a -/-,Small Gut,2.326923077,1.200992556,Radio-Labeled,0.02,PO,24,Adv Drug Deliv Rev,1999,36,179-194,
Ivermectin,WT,Small Gut,1.9375,,Radio-Labeled,0.02,PO,24,Adv Drug Deliv Rev,1999,36,179-194,
Ivermectin,abcb1a -/-,Spleen,0.923076923,1.136094675,Radio-Labeled,0.02,PO,24,Adv Drug Deliv Rev,1999,36,179-194,
Ivermectin,WT,Spleen,0.8125,,Radio-Labeled,0.02,PO,24,Adv Drug Deliv Rev,1999,36,179-194,
Ivermectin,abcb1a -/-,Stomach,2.057692308,0.522588523,Radio-Labeled,0.02,PO,24,Adv Drug Deliv Rev,1999,36,179-194,
Ivermectin,WT,Stomach,3.9375,,Radio-Labeled,0.02,PO,24,Adv Drug Deliv Rev,1999,36,179-194,
Ivermectin,abcb1a -/-,Teste,1.346153846,2.291325696,Radio-Labeled,0.02,PO,24,Adv Drug Deliv Rev,1999,36,179-194,
Ivermectin,WT,Teste,0.5875,,Radio-Labeled,0.02,PO,24,Adv Drug Deliv Rev,1999,36,179-194,
Ivermectin,abcb1a -/-,Thymus,2.326923077,0.865831843,Radio-Labeled,0.02,PO,24,Adv Drug Deliv Rev,1999,36,179-194,
Ivermectin,WT,Thymus,2.6875,,Radio-Labeled,0.02,PO,24,Adv Drug Deliv Rev,1999,36,179-194,
Lapatinib,abcb1a/1b -/-,Brain,0.054671175,4.320295152,LC-MS,72,IV -cont,24,Drug Metab Dispos,2009,37,439-442,
Lapatinib,abcb1a/1b -/-,Brain,0.0292887,3.563457669,LC-MS,7.2,IV -cont,24,Drug Metab Dispos,2009,37,439-442,
Lapatinib,abcg2 -/-,Brain,0.014467005,1.760151864,LC-MS,7.2,IV -cont,24,Drug Metab Dispos,2009,37,439-442,
Lapatinib,abcg2 -/-,Brain,0.013075849,1.033296377,LC-MS,72,IV -cont,24,Drug Metab Dispos,2009,37,439-442,
Lapatinib,TKO,Brain,0.57957746,45.80010747,LC-MS,72,IV -cont,24,Drug Metab Dispos,2009,37,439-442,
Lapatinib,TKO,Brain,0.35810811,43.56980988,LC-MS,7.2,IV -cont,24,Drug Metab Dispos,2009,37,439-442,
Lapatinib,WT,Brain,0.0126545,,LC-MS,72,IV -cont,24,Drug Metab Dispos,2009,37,439-442,
Lapatinib,WT,Brain,0.00821918,,LC-MS,7.2,IV -cont,24,Drug Metab Dispos,2009,37,439-442,
Larotrectinib,cyp2aXAV,Brain,0.046,1.15,LC-MS,15,PO,1,European Journal of Pharmaceutics and Biopharmaceutics,2022,170,197-207,
Larotrectinib,cyp3a -/-,Brain,0.039,0.975,LC-MS,15,PO,1,European Journal of Pharmaceutics and Biopharmaceutics,2022,170,197-207,
Larotrectinib,TKO,Brain,0.25,6.25,LC-MS,10,PO,1,European Journal of Pharmaceutics and Biopharmaceutics,2022,170,197-207,
Larotrectinib,WT,Brain,0.04,,LC-MS,10,PO,1,European Journal of Pharmaceutics and Biopharmaceutics,2022,170,197-207,
Larotrectinib,WT,Brain,0.037,,LC-MS,15,PO,1,European Journal of Pharmaceutics and Biopharmaceutics,2022,170,197-207,
Larotrectinib,cyp2aXAV,Liver,8.8,1.113924051,LC-MS,15,PO,1,European Journal of Pharmaceutics and Biopharmaceutics,2022,170,197-207,
Larotrectinib,cyp3a -/-,Liver,12.5,1.582278481,LC-MS,15,PO,1,European Journal of Pharmaceutics and Biopharmaceutics,2022,170,197-207,
Larotrectinib,TKO,Liver,4.3,0.544303797,LC-MS,10,PO,1,European Journal of Pharmaceutics and Biopharmaceutics,2022,170,197-207,
Larotrectinib,WT,Liver,7.9,,LC-MS,10,PO,1,European Journal of Pharmaceutics and Biopharmaceutics,2022,170,197-207,
Larotrectinib,WT,Liver,9.4,,LC-MS,15,PO,1,European Journal of Pharmaceutics and Biopharmaceutics,2022,170,197-207,
Larotrectinib,cyp2aXAV,Small Gut,30.3,0.410013532,LC-MS,15,PO,1,European Journal of Pharmaceutics and Biopharmaceutics,2022,170,197-207,
Larotrectinib,cyp3a -/-,Small Gut,94.5,1.278755074,LC-MS,15,PO,1,European Journal of Pharmaceutics and Biopharmaceutics,2022,170,197-207,
Larotrectinib,TKO,Small Gut,2.1,0.544303797,LC-MS,10,PO,1,European Journal of Pharmaceutics and Biopharmaceutics,2022,170,197-207,
Larotrectinib,WT,Small Gut,73.9,,LC-MS,10,PO,1,European Journal of Pharmaceutics and Biopharmaceutics,2022,170,197-207,
Larotrectinib,WT,Small Gut,47.3,,LC-MS,15,PO,1,European Journal of Pharmaceutics and Biopharmaceutics,2022,170,197-207,
Larotrectinib,cyp2aXAV,Teste,0.43,1.482758621,LC-MS,15,PO,1,European Journal of Pharmaceutics and Biopharmaceutics,2022,170,197-207,
Larotrectinib,cyp3a -/-,Teste,0.4,1.379310345,LC-MS,15,PO,1,European Journal of Pharmaceutics and Biopharmaceutics,2022,170,197-207,
Larotrectinib,TKO,Teste,0.38,1.310344828,LC-MS,10,PO,1,European Journal of Pharmaceutics and Biopharmaceutics,2022,170,197-207,
Larotrectinib,WT,Teste,0.29,,LC-MS,10,PO,1,European Journal of Pharmaceutics and Biopharmaceutics,2022,170,197-207,
Larotrectinib,WT,Teste,0.23,,LC-MS,15,PO,1,European Journal of Pharmaceutics and Biopharmaceutics,2022,170,197-207,
Levosulpiride,abcb1a -/-,Brain,0.039137203,1.419702024,HPLC,10,PO,2,Neuroscience,2010,169,378-387,
Levosulpiride,WT,Brain,0.027567195,,HPLC,10,PO,2,Neuroscience,2010,169,378-387,
Lorlatinib,TKO,Brain,1.299145299,3.3379872,LC-MS,10,PO,2,International Journal of Cancer,2018,143,2029-2038,
Lorlatinib,WT,Brain,0.389200204,,LC-MS,10,PO,2,International Journal of Cancer,2018,143,2029-2038,
Lorlatinib,abcb1a/1b -/-,Brain,0.119387028,0.8536771,LC-MS,10,PO,8,International Journal of Cancer,2018,143,2029-2038,
Lorlatinib,abcg2 -/-,Brain,0.514660494,3.6800807,LC-MS,10,PO,8,International Journal of Cancer,2018,143,2029-2038,
Lorlatinib,cyp1aXAV,Brain,0.099357101,0.7104531,LC-MS,10,PO,8,International Journal of Cancer,2018,143,2029-2038,
Lorlatinib,cyp3a-/-,Brain,0.101161369,0.7233545,LC-MS,10,PO,8,International Journal of Cancer,2018,143,2029-2038,
Lorlatinib,TKO,Brain,0.519188192,3.712456,LC-MS,10,PO,8,International Journal of Cancer,2018,143,2029-2038,
Lorlatinib,WT,Brain,0.139850327,,LC-MS,10,PO,8,International Journal of Cancer,2018,143,2029-2038,
Lorlatinib,TKO,Teste,1.135852452,2.2054188,LC-MS,10,PO,2,International Journal of Cancer,2018,143,2029-2038,
Lorlatinib,WT,Teste,0.515028018,,LC-MS,10,PO,2,International Journal of Cancer,2018,143,2029-2038,
Milciclib,abcb1a/1b -/-,Brain,2.71,2.277310924,LC-MS,10,PO,4,European Journal of Pharmaceutical Sciences,2021,159,105740,
Milciclib,abcg2 -/-,Brain,1.47,1.235294118,LC-MS,10,PO,4,European Journal of Pharmaceutical Sciences,2021,159,105740,
Milciclib,TKO,Brain,6.13,5.151260504,LC-MS,10,PO,4,European Journal of Pharmaceutical Sciences,2021,159,105740,
Milciclib,WT,Brain,1.19,,LC-MS,10,PO,4,European Journal of Pharmaceutical Sciences,2021,159,105740,
Milciclib,TKO,Brain,2.35,3.916666667,LC-MS,10,PO,24,European Journal of Pharmaceutical Sciences,2021,159,105740,
Milciclib,WT,Brain,0.6,,LC-MS,10,PO,24,European Journal of Pharmaceutical Sciences,2021,159,105740,
Milciclib,abcb1a/1b -/-,Liver,20.51,1.174684994,LC-MS,10,PO,4,European Journal of Pharmaceutical Sciences,2021,159,105740,
Milciclib,WT,Liver,17.46,,LC-MS,10,PO,4,European Journal of Pharmaceutical Sciences,2021,159,105740,
Milciclib,WT,Liver,59.9,,LC-MS,10,PO,24,European Journal of Pharmaceutical Sciences,2021,159,105740,
Milciclib,abcg2 -/-,Liver,16.27,0.931844215,LC-MS,10,PO,4,European Journal of Pharmaceutical Sciences,2021,159,105740,
Milciclib,TKO,Liver,19.45,1.1139748,LC-MS,10,PO,4,European Journal of Pharmaceutical Sciences,2021,159,105740,
Milciclib,TKO,Liver,44.86,0.748914858,LC-MS,10,PO,24,European Journal of Pharmaceutical Sciences,2021,159,105740,
Momelotinib,abcb1a/1b -/-,Brain,0.05488175,2.100151613,LC-MS,10,PO,2,Pharm Res,2015,32,37-46,
Momelotinib,abcg2 -/-,Brain,0.068943338,2.638244271,LC-MS,10,PO,2,Pharm Res,2015,32,37-46,
Momelotinib,TKO,Brain,0.18163772,6.950703115,LC-MS,10,PO,2,Pharm Res,2015,32,37-46,
Momelotinib,WT,Brain,0.02613228,,LC-MS,10,PO,2,Pharm Res,2015,32,37-46,
Momelotinib,abcb1a/1b -/-,Brain,0.00363507,0.485978292,LC-MS,10,PO,8,Pharm Res,2015,32,37-46,
Momelotinib,abcg2 -/-,Brain,0.007479902,7.167128512,LC-MS,10,PO,8,Pharm Res,2015,32,37-46,
Momelotinib,TKO,Brain,0.14791,141.7251159,LC-MS,10,PO,8,Pharm Res,2015,32,37-46,
Momelotinib,WT,Brain,0.00104364,,LC-MS,10,PO,8,Pharm Res,2015,32,37-46,
Morphine,abcb1a -/-,Brain,0.717741935,1.476110773,Radio-Labeled,0.2,IV,4,J Clin Invest,1995,96,1698-1705,
Morphine,WT,Brain,0.486238532,,Radio-Labeled,0.2,IV,4,J Clin Invest,1995,96,1698-1705,
Morphine,abcb1a -/-,Gall Bladder,93.06451613,1.924863806,Radio-Labeled,0.2,IV,4,J Clin Invest,1995,96,1698-1705,
Morphine,WT,Gall Bladder,48.34862385,,Radio-Labeled,0.2,IV,4,J Clin Invest,1995,96,1698-1705,
Morphine,abcb1a -/-,Heart,0.846774194,1.003243338,Radio-Labeled,0.2,IV,4,J Clin Invest,1995,96,1698-1705,
Morphine,WT,Heart,0.844036697,,Radio-Labeled,0.2,IV,4,J Clin Invest,1995,96,1698-1705,
Morphine,abcb1a -/-,Kidney,3.032258065,0.681476555,Radio-Labeled,0.2,IV,4,J Clin Invest,1995,96,1698-1705,
Morphine,WT,Kidney,4.449541284,,Radio-Labeled,0.2,IV,4,J Clin Invest,1995,96,1698-1705,
Morphine,abcb1a -/-,Liver,2.653225806,0.94820201,Radio-Labeled,0.2,IV,4,J Clin Invest,1995,96,1698-1705,
Morphine,WT,Liver,2.798165138,,Radio-Labeled,0.2,IV,4,J Clin Invest,1995,96,1698-1705,
Morphine,abcb1a -/-,Lung,1.661290323,0.968345696,Radio-Labeled,0.2,IV,4,J Clin Invest,1995,96,1698-1705,
Morphine,WT,Lung,1.71559633,,Radio-Labeled,0.2,IV,4,J Clin Invest,1995,96,1698-1705,
Morphine,abcb1a -/-,Muscle,0.64516129,1.098790323,Radio-Labeled,0.2,IV,4,J Clin Invest,1995,96,1698-1705,
Morphine,WT,Muscle,0.587155963,,Radio-Labeled,0.2,IV,4,J Clin Invest,1995,96,1698-1705,
Morphine,abcb1a -/-,Small Gut,2.935483871,0.649021789,Radio-Labeled,0.2,IV,4,J Clin Invest,1995,96,1698-1705,
Morphine,WT,Small Gut,4.52293578,,Radio-Labeled,0.2,IV,4,J Clin Invest,1995,96,1698-1705,
Morphine,abcb1a -/-,Spleen,1.217741935,0.961839645,Radio-Labeled,0.2,IV,4,J Clin Invest,1995,96,1698-1705,
Morphine,WT,Spleen,1.266055046,,Radio-Labeled,0.2,IV,4,J Clin Invest,1995,96,1698-1705,
Morphine,abcb1a -/-,Stomach,1.475806452,0.741303702,Radio-Labeled,0.2,IV,4,J Clin Invest,1995,96,1698-1705,
Morphine,WT,Stomach,1.990825688,,Radio-Labeled,0.2,IV,4,J Clin Invest,1995,96,1698-1705,
Morphine,abcb1a -/-,Teste,1.129032258,0.586021505,Radio-Labeled,0.2,IV,4,J Clin Invest,1995,96,1698-1705,
Morphine,WT,Teste,1.926605505,,Radio-Labeled,0.2,IV,4,J Clin Invest,1995,96,1698-1705,
Morphine,abcb1a -/-,Thymus,0.838709677,0.662459093,Radio-Labeled,0.2,IV,4,J Clin Invest,1995,96,1698-1705,
Morphine,WT,Thymus,1.266055046,,Radio-Labeled,0.2,IV,4,J Clin Invest,1995,96,1698-1705,
Niraparib,abcb1a/1b -/-,Brain,0.066718995,9.3754007,LC-MS,50,PO,4,Mol Pharmaceuticals,2021,18,4371-4384,
Niraparib,abcg2 -/-,Brain,0.749148343,0.8349712,LC-MS,50,PO,4,Mol Pharmaceuticals,2021,18,4371-4384,
Niraparib,TKO,Brain,0.953784219,11.936367,LC-MS,50,PO,4,Mol Pharmaceuticals,2021,18,4371-4384,
Niraparib,WT,Brain,0.079905741,,LC-MS,50,PO,4,Mol Pharmaceuticals,2021,18,4371-4384,
Niraparib,abcb1a/1b -/-,Small Gut,28.52080063,0.184926,LC-MS,50,PO,4,Mol Pharmaceuticals,2021,18,4371-4384,
Niraparib,abcg2 -/-,Small Gut,5.426447817,0.9720374,LC-MS,50,PO,4,Mol Pharmaceuticals,2021,18,4371-4384,
Niraparib,TKO,Small Gut,6.275201288,0.2138695,LC-MS,50,PO,4,Mol Pharmaceuticals,2021,18,4371-4384,
Niraparib,WT,Small Gut,29.34125964,,LC-MS,50,PO,4,Mol Pharmaceuticals,2021,18,4371-4384,
Olamzapine,abcb1a -/-,Brain,2,2.222222222,HPLC,2.5,IP,1,Neuropsychopharmacology,2004,29,551-557,
Olamzapine,WT,Brain,0.9,,HPLC,2.5,IP,1,Neuropsychopharmacology,2004,29,551-557,
Olamzapine,abcb1a -/-,Kidney,4.4,1.692307692,HPLC,2.5,IP,1,Neuropsychopharmacology,2004,29,551-557,
Olamzapine,WT,Kidney,2.6,,HPLC,2.5,IP,1,Neuropsychopharmacology,2004,29,551-557,
Olamzapine,abcb1a -/-,Liver,5.5,2.2,HPLC,2.5,IP,1,Neuropsychopharmacology,2004,29,551-557,
Olamzapine,WT,Liver,2.5,,HPLC,2.5,IP,1,Neuropsychopharmacology,2004,29,551-557,
Olamzapine,abcb1a -/-,Penis,0.8,0.8,HPLC,2.5,IP,1,Neuropsychopharmacology,2004,29,551-557,
Olamzapine,WT,Penis,1,,HPLC,2.5,IP,1,Neuropsychopharmacology,2004,29,551-557,
Olamzapine,abcb1a -/-,Spleen,4.7,0.903846154,HPLC,2.5,IP,1,Neuropsychopharmacology,2004,29,551-557,
Olamzapine,WT,Spleen,5.2,,HPLC,2.5,IP,1,Neuropsychopharmacology,2004,29,551-557,
Olaparib,abcb1a/1b -/-,Brain,0.077278732,6.840744884,LC-MS,60,PO,1,European Journal of Pharmacuetical Sciences,2022,173,106177,
Olaparib,abcg2 -/-,Brain,0.014927536,1.3213916,LC-MS,60,PO,1,European Journal of Pharmacuetical Sciences,2022,173,106177,
Olaparib,TKO,Brain,0.120082531,10.62975465,LC-MS,60,PO,1,European Journal of Pharmacuetical Sciences,2022,173,106177,
Olaparib,WT,Brain,0.01129683,,LC-MS,60,PO,1,European Journal of Pharmacuetical Sciences,2022,173,106177,
Olaparib,abcb1a/1b -/-,Brain - unbound,0.0772,5.594202899,LC-MS,60,PO,1,European Journal of Pharmacuetical Sciences,2022,173,106177,
Olaparib,abcg2 -/-,Brain - unbound,0.0144,1.043478261,LC-MS,60,PO,1,European Journal of Pharmacuetical Sciences,2022,173,106177,
Olaparib,TKO,Brain - unbound,0.111,8.043478261,LC-MS,60,PO,1,European Journal of Pharmacuetical Sciences,2022,173,106177,
Olaparib,WT,Brain - unbound,0.0138,,LC-MS,60,PO,1,European Journal of Pharmacuetical Sciences,2022,173,106177,
Osimertinib,abcb1a/1b -/-,Brain,32.22790698,3.7971972,LC-MS,10,PO,5,Pharmacological Research,2019,146,104297,
Osimertinib,abcg2 -/-,Brain,4.838709677,0.5701126,LC-MS,10,PO,5,Pharmacological Research,2019,146,104297,
Osimertinib,TKO,Brain,47.35981308,5.5800878,LC-MS,10,PO,5,Pharmacological Research,2019,146,104297,
Osimertinib,WT,Brain,8.487288136,,LC-MS,10,PO,5,Pharmacological Research,2019,146,104297,
Osimertinib,abcb1a/1b -/-,Liver,18.29767442,1.1038474,LC-MS,10,PO,5,Pharmacological Research,2019,146,104297,
Osimertinib,WT,Liver,16.57627119,,LC-MS,10,PO,5,Pharmacological Research,2019,146,104297,
Osimertinib,abcg2 -/-,Liver,14.03942652,0.8469593,LC-MS,10,PO,5,Pharmacological Research,2019,146,104297,
Osimertinib,TKO,Liver,11.55140187,0.6968637,LC-MS,10,PO,5,Pharmacological Research,2019,146,104297,
Paclitaxel,abcb1a/1b -/-,Brain,0.035175879,2.040020101,LC-MS,5 ug/mL,IV -cont,3,Cancer Res,2003,16,5114-5117,
Paclitaxel,WT,Brain,0.017241379,,LC-MS,5 ug/mL,IV -cont,3,Cancer Res,2003,16,5114-5117,
Palomid 529,TKO,Brain,1.23320328,1.174179453,HPLC,54,IV,1,International Journal of Cancer,2013,133,1222-1233,
Palomid 529,WT,Brain,1.050268149,,HPLC,54,IV,1,International Journal of Cancer,2013,133,1222-1233,
Palomid 529,TKO,Brain,10.96461586,14.50307489,HPLC,54,IV,4,International Journal of Cancer,2013,133,1222-1233,
Palomid 529,WT,Brain,0.756020081,,HPLC,54,IV,4,International Journal of Cancer,2013,133,1222-1233,
PD0166285,abcb1a/1b -/-,Brain,7.21,6.110169492,LC-MS,5,IV,1,Investigational New Drugs,2018,36,380-387,
PD0166285,abcg2 -/-,Brain,1.01,0.855932203,LC-MS,5,IV,1,Investigational New Drugs,2018,36,380-387,
PD0166285,TKO,Brain,6.17,5.228813559,LC-MS,5,IV,1,Investigational New Drugs,2018,36,380-387,
PD0166285,WT,Brain,1.18,,LC-MS,5,IV,1,Investigational New Drugs,2018,36,380-387,
PD0325901,abcb1a/1b -/-,Brain,1.3,2.275,LC-MS,5,IV,1,International Journal of Cancer,2017,142,381-393,
PD0325901,abcg2 -/-,Brain,0.555555556,0.972222222,LC-MS,5,IV,1,International Journal of Cancer,2017,142,381-393,
PD0325901,TKO,Brain,1.181818182,2.068181818,LC-MS,5,IV,1,International Journal of Cancer,2017,142,381-393,
PD0325901,WT,Brain,0.571428571,,LC-MS,5,IV,1,International Journal of Cancer,2017,142,381-393,
PF-407288,abcb1a/1b -/-,Brain,0.02,2,LC-MS,5,SQ,0.5,Drug Metab Dispos,2009,37,946-961,
PF-407288,abcg2 -/-,Brain,0.02,2,LC-MS,5,SQ,0.5,Drug Metab Dispos,2009,37,946-961,
PF-407288,TKO,Brain,0.03,3,LC-MS,5,SQ,0.5,Drug Metab Dispos,2009,37,946-961,
PF-407288,WT,Brain,0.01,,LC-MS,5,SQ,0.5,Drug Metab Dispos,2009,37,946-961,
PF-407289,abcb1a/1b -/-,Brain,0.02,,LC-MS,5,SQ,2,Drug Metab Dispos,2009,37,946-961,
PF-407289,abcg2 -/-,Brain,0.02,,LC-MS,5,SQ,2,Drug Metab Dispos,2009,37,946-961,
PF-407289,TKO,Brain,0.03,1.5,LC-MS,5,SQ,2,Drug Metab Dispos,2009,37,946-961,
PF-407289,WT,Brain,0.02,,LC-MS,5,SQ,2,Drug Metab Dispos,2009,37,946-961,
Pimasertib,abcb1a/1b -/-,Brain,1.666666667,2.933333333,LC-MS,5,IV,1,International Journal of Cancer,2017,142,381-392,
Pimasertib,abcg2 -/-,Brain,0.589285714,1.037142857,LC-MS,5,IV,1,International Journal of Cancer,2017,142,381-392,
Pimasertib,TKO,Brain,2.291666667,4.033333333,LC-MS,5,IV,1,International Journal of Cancer,2017,142,381-392,
Pimasertib,WT,Brain,0.568181818,,LC-MS,5,IV,1,International Journal of Cancer,2017,142,381-392,
Ponatinib,abcb1a/1b -/-,Brain,2.744444444,2.0849268,LC-MS,10,PO,2,Mol Pharmaceuticals,2017,14,3258-3268,
Ponatinib,abcb1a/1b -/-,Brain,2.16,2.25,LC-MS,10,PO,2,Mol Pharmaceuticals,2017,14,3258-3268,
Ponatinib,abcg2 -/-,Brain,2,1.5193798,LC-MS,10,PO,2,Mol Pharmaceuticals,2017,14,3258-3268,
Ponatinib,abcg2 -/-,Brain,1.06,1.1041667,LC-MS,10,PO,2,Mol Pharmaceuticals,2017,14,3258-3268,
Ponatinib,TKO,Brain,21.85660377,16.604242,LC-MS,10,PO,2,Mol Pharmaceuticals,2017,14,3258-3268,
Ponatinib,TKO,Brain,17.31,18.03125,LC-MS,10,PO,2,Mol Pharmaceuticals,2017,14,3258-3268,
Ponatinib,WT,Brain,1.316326531,,LC-MS,10,PO,2,Mol Pharmaceuticals,2017,14,3258-3268,
Ponatinib,WT,Brain,0.96,,LC-MS,10,PO,2,Mol Pharmaceuticals,2017,14,3258-3268,
Ponatinib,abcb1a/1b -/-,Brain,3.36,1.14608696,LC-MS,10,PO,24,Mol Pharmaceuticals,2017,14,3258-3268,
Ponatinib,abcg2 -/-,Brain,3.08,1.3391304,LC-MS,10,PO,24,Mol Pharmaceuticals,2017,14,3258-3268,
Ponatinib,cyp3-/-,Brain,2.52,1.0956522,LC-MS,10,PO,24,Mol Pharmaceuticals,2017,14,3258-3268,
Ponatinib,TKO,Brain,36.59,15.908696,LC-MS,10,PO,24,Mol Pharmaceuticals,2017,14,3258-3268,
Ponatinib,WT,Brain,2.3,,LC-MS,10,PO,24,Mol Pharmaceuticals,2017,14,3258-3268,
Ponatinib,abcb1a/1b -/-,Liver,79.13,0.9200093,LC-MS,10,PO,2,Mol Pharmaceuticals,2017,14,3258-3268,
Ponatinib,WT,Liver,86.01,,LC-MS,10,PO,2,Mol Pharmaceuticals,2017,14,3258-3268,
Ponatinib,abcb1a/1b -/-,Liver,49.88,0.6096309,LC-MS,10,PO,24,Mol Pharmaceuticals,2017,14,3258-3268,
Ponatinib,WT,Liver,81.82,,LC-MS,10,PO,24,Mol Pharmaceuticals,2017,14,3258-3268,
Ponatinib,abcg2 -/-,Liver,68.81,0.8000233,LC-MS,10,PO,2,Mol Pharmaceuticals,2017,14,3258-3268,
Ponatinib,TKO,Liver,74.31,0.8639693,LC-MS,10,PO,2,Mol Pharmaceuticals,2017,14,3258-3268,
Ponatinib,abcg2 -/-,Liver,59.67,0.7292838,LC-MS,10,PO,24,Mol Pharmaceuticals,2017,14,3258-3268,
Ponatinib,cyp3-/-,Liver,67.6,0.8262039,LC-MS,10,PO,24,Mol Pharmaceuticals,2017,14,3258-3268,
Ponatinib,TKO,Liver,65.03,0.7947934,LC-MS,10,PO,24,Mol Pharmaceuticals,2017,14,3258-3268,
Pralsetinib,abcb1a/1b -/-,Brain,0.25,6.25,LC-MS,10,PO,2,Pharmacological Research,2021,172,105850,
Pralsetinib,abcg2 -/-,Brain,0.072,1.8,LC-MS,10,PO,2,Pharmacological Research,2021,172,105850,
Pralsetinib,TKO,Brain,0.92,23,LC-MS,10,PO,2,Pharmacological Research,2021,172,105850,
Pralsetinib,WT,Brain,0.04,,LC-MS,10,PO,2,Pharmacological Research,2021,172,105850,
Pralsetinib,cyp3a -/-,Brain,0.032,0.106666667,LC-MS,10,PO,8,Pharmacological Research,2021,172,105850,
Pralsetinib,cyp3aXAV,Brain,0.03,0.1,LC-MS,10,PO,8,Pharmacological Research,2021,172,105850,
Pralsetinib,WT,Brain,0.3,,LC-MS,10,PO,8,Pharmacological Research,2021,172,105850,
Pralsetinib,abcb1a/1b -/-,Liver,3.3,0.970588235,LC-MS,10,PO,2,Pharmacological Research,2021,172,105850,
Pralsetinib,WT,Liver,3.4,,LC-MS,10,PO,2,Pharmacological Research,2021,172,105850,
Pralsetinib,WT,Liver,3.1,,LC-MS,10,PO,8,Pharmacological Research,2021,172,105850,
Pralsetinib,abcg2 -/-,Liver,4.1,1.205882353,LC-MS,10,PO,2,Pharmacological Research,2021,172,105850,
Pralsetinib,TKO,Liver,3.8,1.117647059,LC-MS,10,PO,2,Pharmacological Research,2021,172,105850,
Pralsetinib,cyp3a -/-,Liver,3,0.967741935,LC-MS,10,PO,8,Pharmacological Research,2021,172,105850,
Pralsetinib,cyp3aXAV,Liver,2.8,0.903225806,LC-MS,10,PO,8,Pharmacological Research,2021,172,105850,
Pralsetinib,abcg2 -/-,Small Gut,4.8,1.11627907,LC-MS,10,PO,2,Pharmacological Research,2021,172,105850,
Pralsetinib,TKO,Small Gut,2.2,0.511627907,LC-MS,10,PO,2,Pharmacological Research,2021,172,105850,
Pralsetinib,abcb1a/1b -/-,Small Gut,2,0.465116279,LC-MS,10,PO,2,Pharmacological Research,2021,172,105850,
Pralsetinib,WT,Small Gut,4.3,,LC-MS,10,PO,2,Pharmacological Research,2021,172,105850,
Pralsetinib,cyp3a -/-,Small Gut,4.8,0.96,LC-MS,10,PO,8,Pharmacological Research,2021,172,105850,
Pralsetinib,cyp3aXAV,Small Gut,3.1,0.62,LC-MS,10,PO,8,Pharmacological Research,2021,172,105850,
Pralsetinib,WT,Small Gut,5,,LC-MS,10,PO,8,Pharmacological Research,2021,172,105850,
Pralsetinib,abcg2 -/-,Teste,0.071,1.183333333,LC-MS,10,PO,2,Pharmacological Research,2021,172,105850,
Pralsetinib,TKO,Teste,0.47,7.833333333,LC-MS,10,PO,2,Pharmacological Research,2021,172,105850,
Pralsetinib,abcb1a/1b -/-,Teste,0.27,4.5,LC-MS,10,PO,2,Pharmacological Research,2021,172,105850,
Pralsetinib,WT,Teste,0.06,,LC-MS,10,PO,2,Pharmacological Research,2021,172,105850,
Prazosin,abcb1a/1b -/-,Brain,0.23,1.352941176,LC-MS,5,SQ,0.5,Drug Metab Dispos,2009,37,946-959,
Prazosin,abcg2 -/-,Brain,0.31,1.823529412,LC-MS,5,SQ,0.5,Drug Metab Dispos,2009,37,946-959,
Prazosin,TKO,Brain,1.04,6.117647059,LC-MS,5,SQ,0.5,Drug Metab Dispos,2009,37,946-959,
Prazosin,WT,Brain,0.17,,LC-MS,5,SQ,0.5,Drug Metab Dispos,2009,37,946-959,
Prazosin,abcb1a/1b -/-,Brain,0.58,1.757575758,LC-MS,5,SQ,2,Drug Metab Dispos,2009,37,946-959,
Prazosin,abcg2 -/-,Brain,0.37,1.121212121,LC-MS,5,SQ,2,Drug Metab Dispos,2009,37,946-959,
Prazosin,TKO,Brain,1.73,5.242424242,LC-MS,5,SQ,2,Drug Metab Dispos,2009,37,946-959,
Prazosin,WT,Brain,0.33,,LC-MS,5,SQ,2,Drug Metab Dispos,2009,37,946-959,
Quizartinib,abcb1a/1b -/-,Brain,0.52,6.5,LC-MS,10,PO,8,International Journal of Pharmaceutics,2019,556,172-180,
Quizartinib,abcg2 -/-,Brain,0.13,1.625,LC-MS,10,PO,8,International Journal of Pharmaceutics,2019,556,172-180,
Quizartinib,TKO,Brain,1.1,13.75,LC-MS,10,PO,8,International Journal of Pharmaceutics,2019,556,172-180,
Quizartinib,WT,Brain,0.08,,LC-MS,10,PO,8,International Journal of Pharmaceutics,2019,556,172-180,
Quizartinib,abcb1a/1b -/-,Liver,6.56,1.263969171,LC-MS,10,PO,8,International Journal of Pharmaceutics,2019,556,172-180,
Quizartinib,WT,Liver,5.19,,LC-MS,10,PO,8,International Journal of Pharmaceutics,2019,556,172-180,
Quizartinib,abcg2 -/-,Liver,5.7,1.098265896,LC-MS,10,PO,8,International Journal of Pharmaceutics,2019,556,172-180,
Quizartinib,TKO,Liver,4.96,0.955684008,LC-MS,10,PO,8,International Journal of Pharmaceutics,2019,556,172-180,
Regorafenib,abcb1a/1b -/-,Brain,0.00492,0.806557377,LC-MS,10,PO,2,Pharm Res,2015,32,2205-2216,
Regorafenib,abcg2 -/-,Brain,0.0429,7.032786885,LC-MS,10,PO,2,Pharm Res,2015,32,2205-2216,
Regorafenib,TKO,Brain,0.04323,7.086885246,LC-MS,10,PO,2,Pharm Res,2015,32,2205-2216,
Regorafenib,WT,Brain,0.0061,,LC-MS,10,PO,2,Pharm Res,2015,32,2205-2216,
Regorafenib,abcb1a/1b -/-,Brain,0.106,1.364221364,LC-MS,10,PO,24,Pharm Res,2015,32,2205-2216,
Regorafenib,abcg2 -/-,Brain,0.2583,3.324324324,LC-MS,10,PO,24,Pharm Res,2015,32,2205-2216,
Regorafenib,TKO,Brain,0.6236,8.025740026,LC-MS,10,PO,24,Pharm Res,2015,32,2205-2216,
Regorafenib,WT,Brain,0.0777,,LC-MS,10,PO,24,Pharm Res,2015,32,2205-2216,
Regorafenib,abcb1a/1b -/-,Teste,0.7,4.199160168,LC-MS,10,PO,2,Pharm Res,2015,32,2205-2216,
Regorafenib,abcg2 -/-,Teste,1.1625,6.973605279,LC-MS,10,PO,2,Pharm Res,2015,32,2205-2216,
Regorafenib,TKO,Teste,1.05,6.298740252,LC-MS,10,PO,2,Pharm Res,2015,32,2205-2216,
Regorafenib,WT,Teste,0.1667,,LC-MS,10,PO,2,Pharm Res,2015,32,2205-2216,
Repotrectinib,abcb1a/1b -/-,Brain,0.62,4.133333333,LC-MS,10,PO,4,Pharmaceutics,2021,13,1761,
Repotrectinib,abcg2 -/-,Brain,0.14,0.933333333,LC-MS,10,PO,4,Pharmaceutics,2021,13,1761,
Repotrectinib,TKO,Brain,2.13,14.2,LC-MS,10,PO,4,Pharmaceutics,2021,13,1761,
Repotrectinib,WT,Brain,0.15,,LC-MS,10,PO,4,Pharmaceutics,2021,13,1761,
Repotrectinib,abcb1a/1b -/-,Liver,8.9,0.847619048,LC-MS,10,PO,4,Pharmaceutics,2021,13,1761,
Repotrectinib,WT,Liver,10.5,,LC-MS,10,PO,4,Pharmaceutics,2021,13,1761,
Repotrectinib,abcg2 -/-,Liver,6.8,0.647619048,LC-MS,10,PO,4,Pharmaceutics,2021,13,1761,
Repotrectinib,TKO,Liver,7.2,0.685714286,LC-MS,10,PO,4,Pharmaceutics,2021,13,1761,
Repotrectinib,abcg2 -/-,Teste,0.17,0.708333333,LC-MS,10,PO,4,Pharmaceutics,2021,13,1761,
Repotrectinib,TKO,Teste,1.35,5.625,LC-MS,10,PO,4,Pharmaceutics,2021,13,1761,
Repotrectinib,abcb1a/1b -/-,Teste,0.58,2.416666667,LC-MS,10,PO,4,Pharmaceutics,2021,13,1761,
Repotrectinib,WT,Teste,0.24,,LC-MS,10,PO,4,Pharmaceutics,2021,13,1761,
Ribociclib,TKO,Brain,3.038086802,35.56891785,LC-MS,20,PO,4,Mol Pharmaceuticals,2019,16,3842-3852,
Ribociclib,WT,Brain,0.085414091,,LC-MS,20,PO,4,Mol Pharmaceuticals,2019,16,3842-3852,
Ribociclib,abcb1a/1b -/-,Brain,2.598083067,57.3258627,LC-MS,20,PO,8,Mol Pharmaceuticals,2019,16,3842-3852,
Ribociclib,abcg2 -/-,Brain,0.045871007,1.012128927,LC-MS,20,PO,8,Mol Pharmaceuticals,2019,16,3842-3852,
Ribociclib,TKO,Brain,3.246118012,71.6245442,LC-MS,20,PO,8,Mol Pharmaceuticals,2019,16,3842-3852,
Ribociclib,WT,Brain,0.045321308,,LC-MS,20,PO,8,Mol Pharmaceuticals,2019,16,3842-3852,
Ribociclib,cyp3a -/-,Brain,0.003105233,0.974854932,LC-MS,20,PO,24,Mol Pharmaceuticals,2019,16,3842-3852,
Ribociclib,TKO,Brain,1.29204893,405.6250579,LC-MS,20,PO,24,Mol Pharmaceuticals,2019,16,3842-3852,
Ribociclib,WT,Brain,0.003185328,,LC-MS,20,PO,24,Mol Pharmaceuticals,2019,16,3842-3852,
Rucaparib,abcb1a/1b -/-,Brain,0.37689394,2.218623065,LC-MS,10,PO,1,Pharm Res,2015,32,37-47,
Rucaparib,abcg2 -/-,Brain,0.363636364,2.140581046,LC-MS,10,PO,1,Pharm Res,2015,32,37-47,
Rucaparib,TKO,Brain,6.23577236,36.7074843,LC-MS,10,PO,1,Pharm Res,2015,32,37-47,
Rucaparib,WT,Brain,0.16987741,,LC-MS,10,PO,1,Pharm Res,2015,32,37-47,
Rucaparib,abcb1a/1b -/-,Brain,0.03699674,4.259912077,LC-MS,10,PO,24,Pharm Res,2015,32,37-47,
Rucaparib,abcg2 -/-,Brain,0.012298959,1.416137854,LC-MS,10,PO,24,Pharm Res,2015,32,37-47,
Rucaparib,TKO,Brain,0.17065391,19.64958675,LC-MS,10,PO,24,Pharm Res,2015,32,37-47,
Rucaparib,WT,Brain,0.00868486,,LC-MS,10,PO,24,Pharm Res,2015,32,37-47,
Selitrectinib,abcb1a/1b -/-,Brain,0.06,2,LC-MS,10,PO,1,Mol Cancer Ther,2021,20,1173-1182,
Selitrectinib,abcg2 -/-,Brain,0.025,0.833333333,LC-MS,10,PO,1,Mol Cancer Ther,2021,20,1173-1182,
Selitrectinib,TKO,Brain,0.174,5.8,LC-MS,10,PO,1,Mol Cancer Ther,2021,20,1173-1182,
Selitrectinib,WT,Brain,0.03,,LC-MS,10,PO,1,Mol Cancer Ther,2021,20,1173-1182,
Selitrectinib,abcb1a/1b -/-,Liver,0.41,1.025,LC-MS,10,PO,1,Mol Cancer Ther,2021,20,1173-1182,
Selitrectinib,WT,Liver,0.4,,LC-MS,10,PO,1,Mol Cancer Ther,2021,20,1173-1182,
Selitrectinib,abcg2 -/-,Liver,0.7,1.75,LC-MS,10,PO,1,Mol Cancer Ther,2021,20,1173-1182,
Selitrectinib,TKO,Liver,0.7,1.75,LC-MS,10,PO,1,Mol Cancer Ther,2021,20,1173-1182,
Selitrectinib,abcg2 -/-,Teste,0.087,1,LC-MS,10,PO,1,Mol Cancer Ther,2021,20,1173-1182,
Selitrectinib,TKO,Teste,0.337,3.873563218,LC-MS,10,PO,1,Mol Cancer Ther,2021,20,1173-1182,
Selitrectinib,abcb1a/1b -/-,Teste,0.151,1.735632184,LC-MS,10,PO,1,Mol Cancer Ther,2021,20,1173-1182,
Selitrectinib,WT,Teste,0.087,,LC-MS,10,PO,1,Mol Cancer Ther,2021,20,1173-1182,
Selumetinib,abcb1a/1b -/-,Brain,0.060869565,3.043478261,LC-MS,5,IV,1,International Journal of Cancer,2017,142,381-391,
Selumetinib,abcg2 -/-,Brain,0.018181818,0.909090909,LC-MS,5,IV,1,International Journal of Cancer,2017,142,381-391,
Selumetinib,TKO,Brain,0.048275862,2.413793103,LC-MS,5,IV,1,International Journal of Cancer,2017,142,381-391,
Selumetinib,WT,Brain,0.02,,LC-MS,5,IV,1,International Journal of Cancer,2017,142,381-391,
SN-38,abcc4 -/-,Brain,3.45,0.827338129,HPLC,2,IV,1,Clin Cancer Res,2013,19,2084-2095,
SN-38,abcc4 -/-; abcg2 -/-,Brain,0.74,0.177458034,HPLC,2,IV,1,Clin Cancer Res,2013,19,2084-2095,
SN-38,abcc4 -/-; abcg2 -/-; abcb1a/1b -/-,Brain,3.15,0.755395683,HPLC,2,IV,1,Clin Cancer Res,2013,19,2084-2095,
SN-38,abcg2 -/-,Brain,0.56,0.134292566,HPLC,2,IV,1,Clin Cancer Res,2013,19,2084-2095,
SN-38,TKO,Brain,0.76,0.182254197,HPLC,2,IV,1,Clin Cancer Res,2013,19,2084-2095,
SN-38,WT,Brain,4.17,,HPLC,2,IV,1,Clin Cancer Res,2013,19,2084-2095,
Sorafenib,TKO,Brain,0.666666667,4,LC-MS,5,IV,1,Mol Cancer Ther,2010,9,319-329,
Sorafenib,WT,Brain,0.166666667,,LC-MS,5,IV,1,Mol Cancer Ther,2010,9,319-329,
Sorafenib,abcb1a/1b -/-,Brain,0.01641791,0.944029851,LC-MS,10,PO,6,Mol Cancer Ther,2010,9,319-329,
Sorafenib,abcg2 -/-,Brain,0.070422535,4.049295775,LC-MS,10,PO,6,Mol Cancer Ther,2010,9,319-329,
Sorafenib,TKO,Brain,0.173333333,9.966666667,LC-MS,10,PO,6,Mol Cancer Ther,2010,9,319-329,
Sorafenib,WT,Brain,0.017391304,,LC-MS,10,PO,6,Mol Cancer Ther,2010,9,319-329,
Sunitinib,abcb1a/1b -/-,Brain,2.1666667,4.57407415,LC-MS,1.4,SQ - cont.,48,J Pharmacol Exp Ther,2013,347,755-764,
Sunitinib,abcg2 -/-,Brain,0.473684211,1.000000002,LC-MS,1.4,SQ - cont.,48,J Pharmacol Exp Ther,2013,347,755-764,
Sunitinib,TKO,Brain,17.1538462,36.21367535,LC-MS,1.4,SQ - cont.,48,J Pharmacol Exp Ther,2013,347,755-764,
Sunitinib,WT,Brain,0.47368421,,LC-MS,1.4,SQ - cont.,48,J Pharmacol Exp Ther,2013,347,755-764,
Sunitinib,abcb1a/1b -/-,Brain,0.61904762,3.047619052,LC-MS,20,PO,,J Pharmacol Exp Ther,2013,347,755-764,
Sunitinib,abcg2 -/-,Brain,0.4444444,2.188033969,LC-MS,20,PO,,J Pharmacol Exp Ther,2013,347,755-764,
Sunitinib,TKO,Brain,6.57368421,32.36275303,LC-MS,20,PO,,J Pharmacol Exp Ther,2013,347,755-764,
Sunitinib,WT,Brain,0.203125,,LC-MS,20,PO,,J Pharmacol Exp Ther,2013,347,755-764,
Tamoxifen,abcb1a/1b -/-,Brain,10.5,1.296296296,LC-MS,50,PO,1,Journal of Pharmacology and Experimental Therapeutics,2022,383,710-717,
Tamoxifen,WT,Brain,8.1,,LC-MS,50,PO,1,Journal of Pharmacology and Experimental Therapeutics,2022,383,710-717,
Tamoxifen,abcb1a/1b -/-,Brain,36.4,1.555555556,LC-MS,50,PO,4,Journal of Pharmacology and Experimental Therapeutics,2022,383,710-717,
Tamoxifen,WT,Brain,23.4,,LC-MS,50,PO,4,Journal of Pharmacology and Experimental Therapeutics,2022,383,710-717,
Temozolomide,abcb1a/1b -/-,Brain,0.71605518,1.26266265,LC-MS,50,IV,7,Neoplasia,2018,20,710-720,
Temozolomide,abcg2 -/-,Brain,0.71124458,1.27220961,LC-MS,50,IV,7,Neoplasia,2018,20,710-720,
Temozolomide,TKO,Brain,0.88552769,1.57331008,LC-MS,50,IV,7,Neoplasia,2018,20,710-720,
Temozolomide,WT,Brain,0.56284371,,LC-MS,50,IV,7,Neoplasia,2018,20,710-720,
Tivozanib,abcb1a/1b -/-,Brain,0.31,2.214285714,LC-MS,1,PO,8,International Journal of Pharmaceutics,2020,581,119277,
Tivozanib,abcg2 -/-,Brain,0.15,1.071428571,LC-MS,1,PO,8,International Journal of Pharmaceutics,2020,581,119277,
Tivozanib,TKO,Brain,0.37,2.642857143,LC-MS,1,PO,8,International Journal of Pharmaceutics,2020,581,119277,
Tivozanib,WT,Brain,0.14,,LC-MS,1,PO,8,International Journal of Pharmaceutics,2020,581,119277,
Tivozanib,abcb1a/1b -/-,Liver,2.31,1.084507042,LC-MS,1,PO,8,International Journal of Pharmaceutics,2020,581,119277,
Tivozanib,WT,Liver,2.13,,LC-MS,1,PO,8,International Journal of Pharmaceutics,2020,581,119277,
Tivozanib,abcg2 -/-,Liver,1.84,0.863849765,LC-MS,1,PO,8,International Journal of Pharmaceutics,2020,581,119277,
Tivozanib,TKO,Liver,1.65,0.774647887,LC-MS,1,PO,8,International Journal of Pharmaceutics,2020,581,119277,
Topotecan,abcc4 -/-; abcg2 -/-; abcb1a/1b -/-,Brain,1.14,3.081081081,HPLC,2,IV,1,Clin Cancer Res,2013,19,2084-2095,
Topotecan,abcg2 -/-,Brain,0.18,0.486486486,HPLC,2,IV,1,Clin Cancer Res,2013,19,2084-2095,
Topotecan,TKO,Brain,0.59,1.594594595,HPLC,2,IV,1,Clin Cancer Res,2013,19,2084-2095,
Topotecan,WT,Brain,0.37,,HPLC,2,IV,1,Clin Cancer Res,2013,19,2084-2095,
Topotecan,abcc4 -/-; abcg2 -/-; abcb1a/1b -/-,Brain,12.05,7.130177515,HPLC,2,IV,4,Clin Cancer Res,2013,19,2084-2095,
Topotecan,abcg2 -/-,Brain,0.7,0.414201183,HPLC,2,IV,4,Clin Cancer Res,2013,19,2084-2095,
Topotecan,TKO,Brain,9.97,5.899408284,HPLC,2,IV,4,Clin Cancer Res,2013,19,2084-2095,
Topotecan,WT,Brain,1.69,,HPLC,2,IV,4,Clin Cancer Res,2013,19,2084-2095,
Topotecan,abcb1a/1b -/-,Brain,0.642045455,2.033143939,HPLC,5,IV,24,Clin Cancer Res,2007,13,6440-6449,
Topotecan,abcg2 -/-,Brain,0.213774597,0.676952892,HPLC,5,IV,24,Clin Cancer Res,2007,13,6440-6449,
Topotecan,TKO,Brain,1.019897669,3.229675952,HPLC,5,IV,24,Clin Cancer Res,2007,13,6440-6449,
Topotecan,WT,Brain,0.315789474,,HPLC,5,IV,24,Clin Cancer Res,2007,13,6440-6449,
Topotecan,abcb1a/1b -/-,Heart,2.650568182,1.057999905,HPLC,5,IV,24,Clin Cancer Res,2007,13,6440-6449,
Topotecan,abcg2 -/-,Heart,2.58765653,1.032888111,HPLC,5,IV,24,Clin Cancer Res,2007,13,6440-6449,
Topotecan,TKO,Heart,2.427515634,0.968966324,HPLC,5,IV,24,Clin Cancer Res,2007,13,6440-6449,
Topotecan,WT,Heart,2.505263158,,HPLC,5,IV,24,Clin Cancer Res,2007,13,6440-6449,
Topotecan,abcb1a/1b -/-,Kidney,31.20738636,3.365472939,HPLC,5,IV,24,Clin Cancer Res,2007,13,6440-6449,
Topotecan,abcg2 -/-,Kidney,9.272808587,0.271938265,HPLC,5,IV,24,Clin Cancer Res,2007,13,6440-6449,
Topotecan,TKO,Kidney,11.08925526,0.32520814,HPLC,5,IV,24,Clin Cancer Res,2007,13,6440-6449,
Topotecan,WT,Kidney,34.09894737,,HPLC,5,IV,24,Clin Cancer Res,2007,13,6440-6449,
Topotecan,abcb1a/1b -/-,Liver,11.03409091,1.090325189,HPLC,5,IV,24,Clin Cancer Res,2007,13,6440-6449,
Topotecan,abcg2 -/-,Liver,9.072450805,0.896487234,HPLC,5,IV,24,Clin Cancer Res,2007,13,6440-6449,
Topotecan,TKO,Liver,8.284820921,0.818658194,HPLC,5,IV,24,Clin Cancer Res,2007,13,6440-6449,
Topotecan,WT,Liver,10.12,,HPLC,5,IV,24,Clin Cancer Res,2007,13,6440-6449,
Topotecan,abcb1a/1b -/-,Lung,3.627840907,0.883251886,HPLC,5,IV,24,Clin Cancer Res,2007,13,6440-6449,
Topotecan,abcg2 -/-,Lung,3.985688737,0.970375269,HPLC,5,IV,24,Clin Cancer Res,2007,13,6440-6449,
Topotecan,TKO,Lung,3.943149517,0.960018462,HPLC,5,IV,24,Clin Cancer Res,2007,13,6440-6449,
Topotecan,WT,Lung,4.107368423,,HPLC,5,IV,24,Clin Cancer Res,2007,13,6440-6449,
Topotecan,abcb1a/1b -/-,Spleen,9.735795455,0.989833656,HPLC,5,IV,24,Clin Cancer Res,2007,13,6440-6449,
Topotecan,abcg2 -/-,Spleen,5.464221825,0.555544813,HPLC,5,IV,24,Clin Cancer Res,2007,13,6440-6449,
Topotecan,TKO,Spleen,9.245594088,0.939995118,HPLC,5,IV,24,Clin Cancer Res,2007,13,6440-6449,
Topotecan,WT,Spleen,9.835789474,,HPLC,5,IV,24,Clin Cancer Res,2007,13,6440-6449,
Trametinib,abcb1a/1b -/-,Brain,0.375,12.5,LC-MS,5,IV,1,Drug Metab Dispos,2014,42,1292-1300,
Trametinib,abcg2 -/-,Brain,0.02,0.666666667,LC-MS,5,IV,1,Drug Metab Dispos,2014,42,1292-1300,
Trametinib,TKO,Brain,0.583333333,19.44444444,LC-MS,5,IV,1,Drug Metab Dispos,2014,42,1292-1300,
Trametinib,WT,Brain,0.03,,LC-MS,5,IV,1,Drug Metab Dispos,2014,42,1292-1300,
Trametinib,abcb1a/1b -/-,Brain,0.8,22.22222222,LC-MS,5,IV,4,Drug Metab Dispos,2014,42,1292-1300,
Trametinib,abcg2 -/-,Brain,0.06,1.666666667,LC-MS,5,IV,4,Drug Metab Dispos,2014,42,1292-1300,
Trametinib,TKO,Brain,0.6,16.66666667,LC-MS,5,IV,4,Drug Metab Dispos,2014,42,1292-1300,
Trametinib,WT,Brain,0.036,,LC-MS,5,IV,4,Drug Metab Dispos,2014,42,1292-1300,
Trametinib,abcb1a/1b -/-,Brain,0.55,16.04166667,LC-MS,5,IV,8,Drug Metab Dispos,2014,42,1292-1300,
Trametinib,abcg2 -/-,Brain,0.25,7.291666667,LC-MS,5,IV,8,Drug Metab Dispos,2014,42,1292-1300,
Trametinib,TKO,Brain,0.818181818,23.86363636,LC-MS,5,IV,8,Drug Metab Dispos,2014,42,1292-1300,
Trametinib,WT,Brain,0.034285714,,LC-MS,5,IV,8,Drug Metab Dispos,2014,42,1292-1300,
Trametinib,abcb1a/1b -/-,Brain,1.2,3.333333333,LC-MS,5,IV,16,Drug Metab Dispos,2014,42,1292-1300,
Trametinib,abcg2 -/-,Brain,0.714285714,1.984126984,LC-MS,5,IV,16,Drug Metab Dispos,2014,42,1292-1300,
Trametinib,TKO,Brain,1,2.777777778,LC-MS,5,IV,16,Drug Metab Dispos,2014,42,1292-1300,
Trametinib,WT,Brain,0.36,,LC-MS,5,IV,16,Drug Metab Dispos,2014,42,1292-1300,
Trametinib,abcb1a/1b -/-,Brain,1.333333333,3.333333333,LC-MS,5,IV,24,Drug Metab Dispos,2014,42,1292-1300,
Trametinib,abcg2 -/-,Brain,0.35,0.875,LC-MS,5,IV,24,Drug Metab Dispos,2014,42,1292-1300,
Trametinib,TKO,Brain,2.727272727,6.818181818,LC-MS,5,IV,24,Drug Metab Dispos,2014,42,1292-1300,
Trametinib,WT,Brain,0.4,,LC-MS,5,IV,24,Drug Metab Dispos,2014,42,1292-1300,
Trimipramine,abcb1a/1b -/-,Brain,6.995967742,0.717567451,HPLC,10,SC,1,Journal of Psychiatric Research,2003,37,179-185,
Trimipramine,WT,Brain,9.749561147,,HPLC,10,SC,1,Journal of Psychiatric Research,2003,37,179-185,
Trimipramine,abcb1a/1b -/-,Kidney,12.59425403,1.004413652,HPLC,10,SC,1,Journal of Psychiatric Research,2003,37,179-185,
Trimipramine,WT,Kidney,12.53891164,,HPLC,10,SC,1,Journal of Psychiatric Research,2003,37,179-185,
Trimipramine,abcb1a/1b -/-,Liver,2.06703629,0.986199056,HPLC,10,SC,1,Journal of Psychiatric Research,2003,37,179-185,
Trimipramine,WT,Liver,2.095962551,,HPLC,10,SC,1,Journal of Psychiatric Research,2003,37,179-185,
Trimipramine,abcb1a/1b -/-,Spleen,11.54737903,1.024528645,HPLC,10,SC,1,Journal of Psychiatric Research,2003,37,179-185,
Trimipramine,WT,Spleen,11.27091867,,HPLC,10,SC,1,Journal of Psychiatric Research,2003,37,179-185,
Veliparib,abcb1a/1b -/-,Brain,2.71823682,3.144135686,HPLC,10,IV,4,Clin Cancer Res,2013,19,2084-2095,
Veliparib,abcg2 -/-,Brain,0.76070529,0.87989414,HPLC,10,IV,4,Clin Cancer Res,2013,19,2084-2095,
Veliparib,TKO,Brain,3.20354665,3.705484846,HPLC,10,IV,4,Clin Cancer Res,2013,19,2084-2095,
Veliparib,TKO,Brain,0.86956522,6.382608809,HPLC,10,PO,4,Clin Cancer Res,2013,19,2084-2095,
Veliparib,WT,Brain,0.86454183,,HPLC,10,IV,4,Clin Cancer Res,2013,19,2084-2095,
Veliparib,WT,Brain,0.13623978,,HPLC,10,PO,4,Clin Cancer Res,2013,19,2084-2095,
Vemurafenib,TKO,Brain,0.1,7.142857143,LC-MS,2.5,IV,0,J Pharmacol Exp Ther,2012,342,33-40,
Vemurafenib,WT,Brain,0.014,,LC-MS,2.5,IV,0,J Pharmacol Exp Ther,2012,342,33-40,
Vemurafenib,abcb1a/1b -/-,Brain,0.03,1.2,LC-MS,25,PO,1,J Pharmacol Exp Ther,2012,342,33-40,
Vemurafenib,abcg2 -/-,Brain,0.025,,LC-MS,25,PO,1,J Pharmacol Exp Ther,2012,342,33-40,
Vemurafenib,TKO,Brain,0.3333,100.0900901,LC-MS,2.5,IV,1,J Pharmacol Exp Ther,2012,342,33-40,
Vemurafenib,TKO,Brain,0.8,32,LC-MS,25,PO,1,J Pharmacol Exp Ther,2012,342,33-40,
Vemurafenib,WT,Brain,0.025,,LC-MS,25,PO,1,J Pharmacol Exp Ther,2012,342,33-40,
Vemurafenib,WT,Brain,0.00333,,LC-MS,2.5,IV,1,J Pharmacol Exp Ther,2012,342,33-40,
Vemurafenib,TKO,Brain,0.36,36,LC-MS,2.5,IV,2,J Pharmacol Exp Ther,2012,342,33-40,
Vemurafenib,WT,Brain,0.01,,LC-MS,2.5,IV,2,J Pharmacol Exp Ther,2012,342,33-40,
Vemurafenib,TKO,Brain,0.4,200,LC-MS,2.5,IV,3.5,J Pharmacol Exp Ther,2012,342,33-40,
Vemurafenib,WT,Brain,0.002,,LC-MS,2.5,IV,3.5,J Pharmacol Exp Ther,2012,342,33-40,
Vemurafenib,abcb1a/1b -/-,Brain,0.03,3,LC-MS,25,PO,4,J Pharmacol Exp Ther,2012,342,33-40,
Vemurafenib,abcg2 -/-,Brain,0.02,2,LC-MS,25,PO,4,J Pharmacol Exp Ther,2012,342,33-40,
Vemurafenib,TKO,Brain,0.5,50,LC-MS,25,PO,4,J Pharmacol Exp Ther,2012,342,33-40,
Vemurafenib,WT,Brain,0.01,,LC-MS,25,PO,4,J Pharmacol Exp Ther,2012,342,33-40,
Vemurafenib,TKO,Brain,0.66667,249.6891386,LC-MS,2.5,IV,6,J Pharmacol Exp Ther,2012,342,33-40,
Vemurafenib,WT,Brain,0.00267,,LC-MS,2.5,IV,6,J Pharmacol Exp Ther,2012,342,33-40,
Vemurafenib,TKO,Brain,0.6,60,LC-MS,2.5,IV,9,J Pharmacol Exp Ther,2012,342,33-40,
Vemurafenib,WT,Brain,0.01,,LC-MS,2.5,IV,9,J Pharmacol Exp Ther,2012,342,33-40,
Vemurafenib,abcb1a/1b -/-,Brain,0.0375,3.75,LC-MS,1200,IV,48,J Pharmacol Exp Ther,2012,342,33-40,
Vemurafenib,abcg2 -/-,Brain,0.016,1.6,LC-MS,1200,IV,48,J Pharmacol Exp Ther,2012,342,33-40,
Vemurafenib,TKO,Brain,1,100,LC-MS,1200,IV,48,J Pharmacol Exp Ther,2012,342,33-40,
Vemurafenib,WT,Brain,0.01,,LC-MS,1200,IV,48,J Pharmacol Exp Ther,2012,342,33-40,
Vinblastine,abcb1a -/-,Brain,18.666667,11.19999796,Radio-Labeled,1,IV,4,Adv Drug Deliv Rev,1999,36,179-194,
Vinblastine,WT,Brain,1.666667,,Radio-Labeled,1,IV,4,Adv Drug Deliv Rev,1999,36,179-194,
Vinblastine,abcb1a -/-,Caecum,78.33333333,1.944680851,Radio-Labeled,1,IV,4,Adv Drug Deliv Rev,1999,36,179-194,
Vinblastine,WT,Caecum,152.3333333,,Radio-Labeled,1,IV,4,Adv Drug Deliv Rev,1999,36,179-194,
Vinblastine,abcb1a -/-,Colon,74,1.037383178,Radio-Labeled,1,IV,4,Adv Drug Deliv Rev,1999,36,179-194,
Vinblastine,WT,Colon,71.33333333,,Radio-Labeled,1,IV,4,Adv Drug Deliv Rev,1999,36,179-194,
Vinblastine,abcb1a -/-,Epododumis,39.66666667,0.510729614,Radio-Labeled,1,IV,4,Adv Drug Deliv Rev,1999,36,179-194,
Vinblastine,WT,Epododumis,77.66666667,,Radio-Labeled,1,IV,4,Adv Drug Deliv Rev,1999,36,179-194,
Vinblastine,abcb1a -/-,Fat (neck),53.5,0.753521127,Radio-Labeled,1,IV,4,Adv Drug Deliv Rev,1999,36,179-194,
Vinblastine,WT,Fat (neck),71,,Radio-Labeled,1,IV,4,Adv Drug Deliv Rev,1999,36,179-194,
Vinblastine,abcb1a -/-,Fat (organ),12.16666667,0.414772727,Radio-Labeled,1,IV,4,Adv Drug Deliv Rev,1999,36,179-194,
Vinblastine,WT,Fat (organ),29.33333333,,Radio-Labeled,1,IV,4,Adv Drug Deliv Rev,1999,36,179-194,
Vinblastine,abcb1a -/-,Gall Bladder,77.66666667,0.68128655,Radio-Labeled,1,IV,4,Adv Drug Deliv Rev,1999,36,179-194,
Vinblastine,WT,Gall Bladder,114,,Radio-Labeled,1,IV,4,Adv Drug Deliv Rev,1999,36,179-194,
Vinblastine,abcb1a -/-,Heart,36.5,1.7109375,Radio-Labeled,1,IV,4,Adv Drug Deliv Rev,1999,36,179-194,
Vinblastine,WT,Heart,21.33333333,,Radio-Labeled,1,IV,4,Adv Drug Deliv Rev,1999,36,179-194,
Vinblastine,abcb1a -/-,Kidney,155.3333333,1.167919799,Radio-Labeled,1,IV,4,Adv Drug Deliv Rev,1999,36,179-194,
Vinblastine,WT,Kidney,133,,Radio-Labeled,1,IV,4,Adv Drug Deliv Rev,1999,36,179-194,
Vinblastine,abcb1a -/-,Liver,46.83333333,1.22173913,Radio-Labeled,1,IV,4,Adv Drug Deliv Rev,1999,36,179-194,
Vinblastine,WT,Liver,38.33333333,,Radio-Labeled,1,IV,4,Adv Drug Deliv Rev,1999,36,179-194,
Vinblastine,abcb1a -/-,Lung,176.3333333,1.023210832,Radio-Labeled,1,IV,4,Adv Drug Deliv Rev,1999,36,179-194,
Vinblastine,WT,Lung,172.3333333,,Radio-Labeled,1,IV,4,Adv Drug Deliv Rev,1999,36,179-194,
Vinblastine,abcb1a -/-,Lymph Node,82.66666667,0.629441624,Radio-Labeled,1,IV,4,Adv Drug Deliv Rev,1999,36,179-194,
Vinblastine,WT,Lymph Node,131.3333333,,Radio-Labeled,1,IV,4,Adv Drug Deliv Rev,1999,36,179-194,
Vinblastine,abcb1a -/-,Muscle,24.66666667,3.363636364,Radio-Labeled,1,IV,4,Adv Drug Deliv Rev,1999,36,179-194,
Vinblastine,WT,Muscle,7.333333333,,Radio-Labeled,1,IV,4,Adv Drug Deliv Rev,1999,36,179-194,
Vinblastine,abcb1a -/-,Small Gut,96.16666667,1.464467005,Radio-Labeled,1,IV,4,Adv Drug Deliv Rev,1999,36,179-194,
Vinblastine,WT,Small Gut,65.66666667,,Radio-Labeled,1,IV,4,Adv Drug Deliv Rev,1999,36,179-194,
Vinblastine,abcb1a -/-,Spleen,240.3333333,0.823059361,Radio-Labeled,1,IV,4,Adv Drug Deliv Rev,1999,36,179-194,
Vinblastine,WT,Spleen,292,,Radio-Labeled,1,IV,4,Adv Drug Deliv Rev,1999,36,179-194,
Vinblastine,abcb1a -/-,Stomach,92.16666667,0.8640625,Radio-Labeled,1,IV,4,Adv Drug Deliv Rev,1999,36,179-194,
Vinblastine,WT,Stomach,106.6666667,,Radio-Labeled,1,IV,4,Adv Drug Deliv Rev,1999,36,179-194,
Vinblastine,abcb1a -/-,Teste,10.66666667,1.230769231,Radio-Labeled,1,IV,4,Adv Drug Deliv Rev,1999,36,179-194,
Vinblastine,WT,Teste,8.666666667,,Radio-Labeled,1,IV,4,Adv Drug Deliv Rev,1999,36,179-194,
Vinblastine,abcb1a -/-,Thymus,71,0.674050633,Radio-Labeled,1,IV,4,Adv Drug Deliv Rev,1999,36,179-194,
Vinblastine,WT,Thymus,105.3333333,,Radio-Labeled,1,IV,4,Adv Drug Deliv Rev,1999,36,179-194,